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Sudden cardiac death is a well-documented public health problem resulting in 400,000 
deaths in the U.S. annually. The Implantable Cardioverter Defibrillator (ICD) has 
demonstrated benefit in reducing mortality in at risk patients.  Despite the benefits of 
this device in treating life threatening ventricular arrhythmias, prospective patients have 
specific concerns about the challenges of living with an ICD. These concerns include 
biomedical risks, social deficits, psychological difficulties, and existential beliefs. 
However, there are no known measures that assess patient’s perceptions of the ICD 
prior to implantation. In the current study, a measure regarding beliefs about the ICD 
was created, and then a sample of prospective ICD recipients completed the measure 
by rating their beliefs about the ICD. Factor analysis was performed to assess the 
relationship between the variables. Measures of psychopathology, quality of life, 
religious health fatalism, and locus of control were also completed by participants for 
preliminary validity estimates and to assess relationships between variables. The 
current study examined patient decision-making regarding the ICD and developed a 2-
factor pro and con measurement approach. The ICD-DAS is comprised of 22 essential 
items with 2 factors labeled: ICD Pros and ICD Cons. The utility of this measure will 
allow for the provision of patient driven education and counseling and can be used in 
developing decision aid materials for prospective ICD patients. 
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CHAPTER 1: LITERATURE REVIEW 
Sudden Cardiac Death 
 Sudden cardiac death (SCD) occurs when the heart unexpectedly and swiftly 
ceases to function. In the U.S. alone, at least 400,000 people are affected annually 
(Goldberger et al., 2008; Turakhia & Tseng, 2007). The onset of SCD is called sudden 
cardiac arrest (SCA) and is most commonly caused by a ventricular tachyarrhythmia 
(VT) that degenerates into ventricular fibrillation (VF). The electrical system of the heart 
begins to malfunction and an individual can die within approximately 10 minutes. 
 In many cases, patients with SCA have no prior symptoms. It has been estimated 
by the Center for Disease Control (CDC) that U.S. survival for SCA is approximately 5% 
(Zheng, Croft, Giles, & Mensah, 2001). When patients survive SCA or are found to be at 
risk for VT/VF, the most common treatments to prevent recurrence are anti-arrhythmic 
medication and/or an implantable cardioverter defibrillator (ICD). Frequently prescribed 
anti-arrhythmic medications include ACE inhibitors, beta-blockers, and calcium channel 
blockers to achieve heart rate and rhythm control. In most cases, these medications are 
used in combination with the ICD.  Many SCA patients have a compromised left 
ventricular ejection fraction, which is the fraction of blood pumped with each heartbeat 
from the left ventricle. Normal ejection fractions can range between 55-75%.  Reduced 
ejection fraction is one of the few reliable predictors of SCA.  
The Implantable Cardioverter Defibrillator (ICD) 
The ICD has established life-saving benefits in several randomized trials of 
patients at risk for life-threatening ventricular arrhythmias (Bardy, Lee, Mark, et al., 
2005; Buxton et al., 1999; Connolly et al., 2000; Kuck, Cappato, Siebels, & Ruppel, 
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2000; Moss et al., 2002). The ICD is a device used to treat patients at risk for recurring, 
sustained ventricular tachycardia (VT) or ventricular fibrillation (VF). The device is 
typically implanted and fixed under the clavicle in the left pectoral region of the upper 
portion of the chest. Inside the device is a pulse generator that is powered by a battery. 
The battery life is typically 4-6 years, but this depends on the amount of pacing utilized 
and the number of ICD discharges (Kenny, 2006). Leads from the pulse generator are 
attached to the right chambers of the heart including the right atrium or right ventricle. 
The device circuitry constantly records heart rhythms, evaluates their potential for 
lethality, and follows a treatment algorithm programmed by the attending physician. The 
primary purpose of the ICD is the detection and termination of arrhythmias by providing 
an electrical shock. If the ICD detects VT/VF or other problematic rates/rhythms, it 
shocks the heart to restore a normal rate and rhythm and aborts the potentially life-
threatening arrhythmia. The ICD also has extensive memory capabilities allowing for 
precise diagnostics and triage of cardiac rate and rhythms. 
ICD Indication 
The ICD was originally designed for the secondary prevention of SCD following 
the survival of SCA. The first human implant was achieved in 1980, and the ICD was 
FDA approved in 1985 (Mirowski, 1985). By 1990, implantation rates were at about 
10,000 each year and climbed in 2000, reaching up to 90,000.  More recently, U.S. 
rates of implantation were estimated at 200,000 for 2007. Major randomized clinical 
trials comparing medications to ICD including the Antiarrhythmics Versus Implantable 
Defibrillators (AVID) trial (AVID Investigators, 1997), the Canadian Implantable 
Defibrillator Study (CIDS) (Connolly et al., 2000), and the Cardiac Arrest Study Of 
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Hamburg (CASH) (Kuck et al., 2000), demonstrated the superiority of the ICD in 
preventing mortality. These studies, presented in Table 1, provided the empirical 
evidence for secondary prevention indications over anti-arrhythmic medication alone in 
preventing SCD. The relative risk reduction of ICDs versus anti-arrhythmic medications 
ranged from no benefit to a 69% decrease of mortality, depending on the timing of 
implantation, type of disease, and degree of disease severity in the population studied.  
As previously mentioned, the survival rate for SCD in the U.S. is 5%, meaning 
95% of patients could possibly be targeted at the primary prevention level. A dramatic 
increase in recipients has resulted due to a set of successful and progressive clinical 
trials highlighting the value and utility of the ICD, including the Multicenter Automatic 
Defibrillator Implantation Trial (MADIT) (Moss et al., 1996), The Coronary Artery Bypass 
Graft Patch Trial (CABG-PATCH) (Namerow, Firth, Heywood, Windle, & Parides, 1999), 
the Multicenter Unsustained Tachycardia Trial (MUSTT) (Buxton et al., 1999), the 
Multicenter Unsustained Tachycardia Trial II (MADIT II) (Moss et al., 2002), the 
Prophylactic Defibrillator Implantation In Patients With Nonischemic Dilated 
Cardiomyopathy Trial (DEFINITE) (Kadish et al., 2004), the Prophylactic Use Of An 
Implantable Cardioverter-Defibrillator After Acute Myocardial Infarction Trial (DINAMIT) 
(Hohnloser et al., 2004), and the Sudden Cardiac Death In Heart Failure Trial (SCD-
HeFT) (Bardy et al., 2005), which consistently showed the unique and added mortality 
prevention benefit over the effects of optimal medical therapy. These trials are 
summarized in Table 1. After these trials, patients with (a) New York Heart Association 
(NYHA) class I, II, or III with prior myocardial infarction, (b) those with a left ventricular 
ejection fraction (LVEF) of less than 35%, (c) those with documented asymptomatic 
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unsustained ventricular tachyarrhythmia, or (c) those with inducible, non-suppressible 
ventricular tachyarrhythmia were indicated to receive the ICD. These results triggered 
new Medicare guidelines for the primary prevention of SCD that broadly covered the 
financial cost of ICDs for Medicare patients. After SCD-HeFT (Bardy et al., 2005), the 
Center for Medicare and Medicaid Services made an aim to “support the development of 
additional evidence that can help doctors and patients make more informed decisions” 
(McClellan & Tunis, 2005, p. 223). To make informed decisions, patients must have 
accurate and relevant information concerning the risks and benefits of the ICD; 
however, little is know about the relative considerations of ICD patients at this time. 
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Table 1 
Important ICD Trials 
 
 
Trial Name  
 
 
Primary vs. 
Secondary  
Prevention-
Indication 
 
Publication Year 
 
N 
 
Relative Risk 
Reduction 
 
 
MADIT  
 
 
P 
 
1996 
 
196 
 
.46* 
AVID  S 1997 1016 .62* 
CABG-Patch  P 1997 900 1.07 
CASH  S 2000 191 .83 
CIDS  S 2000 659 .82 
MADIT-II  P 2002 1232 .69* 
DEFINITE  P 2004 458 .65 
DINAMIT  P 2004 674 1.08 
SCD-HeFT  P 2005 1676 .77* 
* Statistically significant difference between groups. 
Note. A relative risk of < 1 means all cause mortality is less likely to occur in the ICD 
group than in the comparison group. 
 
Until 2005, each year since the ICD was first introduced (Mirowski, 1985), 
implantation rates had increased in the United States indicating progressive acceptance 
of the ICD by physicians and patients.  However, since 2005, implantations rates have 
begun to level off or drop slightly (Feder, 2008), with some suggesting that an initial 
overestimation of ICD benefits occurred based on flawed clinical trials (Tung, 
Zimetbaum, & Josephson, 2008). Others argue that these very thorough clinical trials 
may have had flaws, but these do not discount the life saving benefits of ICD therapy 
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(Epstein, 2008). Generally, the downturn could be attributed to both physicians and their 
patients deciding the risks of the ICD outweigh potential benefits. Specifically, downturn 
in utilization could possibly be the result of negative device perceptions about value, 
safety, and utility. Because ICDs save lives, choosing the ICD has often been presumed 
to be the correct choice, and in turn, psychosocial research has focused on the care for 
poorly adjusted patients who have received a device.  
Pre-Implant Versus Post-Implant Psychosocial Care 
 Some ICD patients experience lower quality of life and increased anxiety and 
depression, and the primary patient care strategy has been to treat patients who are not 
adjusting well. Specifically, the focus of the existing research on assessment (e.g., 
Sears & Conti, 2002) and intervention (e.g., Kuijpers, Honig, & Wellens, 2002; 
Pedersen, van den Broek, & Sears, 2007) has been on the post-operative end. Despite 
effective efforts, the day-to-day standard of care for patients both before and after 
implant often falls short in addressing concerns and problems with daily functioning 
(Steinke, Gill-Hopple, Valdez, & Woostr, 2005). The focus of the current research 
emphasizes the need for assessment and intervention prior to implantation as a part of 
the decision-making process for prospective ICD patients.  
With thousands of Americans receiving an ICD each year, anticipating the 
potential challenges to adjustment and acceptance of the device is imperative to the 
quality of life of many cardiac patients. Through this anticipation, providing patient-
centered assistance in making an informed decision can target patient concerns and 
misconceptions. By assisting patients in weighing the pros and cons of the ICD, 
providers will be enabled to assess individualized concerns and eventually allow for 
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education and treatment specification prior to implant. With this patient relevant 
risk/benefit information available, an objective format for providers can be utilized. 
The ability to provide more precise interventions prior to implant would be 
financially efficient, save provider time, and most importantly, prevent unnecessary 
patient distress. Moreover, this strategy would permit individualized and more 
appropriate informed consent.  Most importantly, acknowledging and attempting to 
resolve patient concerns about the ICD is of grave importance. More specifically, 
patients who do not receive clinically indicated ICD therapy experience chances of 
death that are significantly increased with each year compared to that of ICD recipients 
(Koller et al., 2008). If patients decide against the ICD because they have not been 
appropriately or adequately informed, the potential benefit of the ICD is lost.    
Educational Procedures for Prospective ICD Patients 
Current educational procedures for ICD-indicated patients are not standardized 
and are likely to provide only very basic risk/benefit information about the various 
treatment options for their condition. While their providers review some risks and 
benefits of the ICD to patients, many ICD recipients may hold misconceptions about the 
ICD, with more than half believing ICDs would save 50% of lives over the course of 5 
years (Stewart et al., 2006). A more accurate statement would be that 25% would be 
saved over 5 years, using the SCD-HeFT data as a guide. Moreover, greater than 95% 
overestimate the number of lives saved by the device (Bardy et al., 2005). Despite the 
effectiveness of the ICD, these misconceptions may represent a chasm between the 
facts of the ICD and patient beliefs.  This might suggest that ICD patients are not 
recalling information reliably or accurately or current informed consent procedures fail to 
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meet patient needs. With these patient misconceptions present, more comprehensive 
risk and benefit information and clarification is needed.  
Providing patients the best objective information about the facts of any procedure 
is the goal. Ajzen and Fishbein (1980) noted there are ethical considerations to be 
considered any time information is provided to patients, as this is a form of persuasion. 
They state that with persuasion inherent in the provision of information, the goal should 
be to include all relevant information in an accurate manner.  Ideally, when providing the 
facts about the ICD, characteristics of the patient, the decision, the physician, and the 
method of information delivery should be considered.  Most importantly, providers can 
accommodate patient preferences for treatment to help patients reach an informed 
medical decision. However, educational procedures are largely based on scripted 
discussion of facts mixed with some subjective interpretation of patient needs, 
prognosis, and beliefs about the patient. Also, limitations in the educational process are 
generally acknowledged as a result of (a) the limited time schedules of providers, (b) the 
challenges of doctor-patient communication, (c) patient factors such as distress, 
educational level, or comfort level of decision making, and (d) a lack of evidence to 
promote a change in the current information-sharing strategies. Provision of educational 
materials is often seen as a legal obligation, rather than an opportunity to help the 
patient make a highly customized decision based on the available information (Paling, 
2006). Unless patients request detailed information, they likely will not obtain knowledge 
of many of the advantages and disadvantages to either the receipt or refusal of the ICD.  
The lack of current educational standards surrounding the ICD highlights the need to 
identify the beliefs about the ICD for prospective patients. Identifying these factors is 
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difficult because there are a multitude of potential influences on the decision-making 
process of potential ICD patients. 
Decisional Influences 
 Decision research also details an array of cognitive, emotional, and social factors 
which influence decision-making (Patel, Kaufman, & Arocha, 2002; Tversky & 
Kahneman, 1974). The following review examines important factors that influence 
patient decision making with an emphasis on those factors that have particular 
relevance for the ICD decision. The intent of this review is to provide a rationale for this 
study’s consideration of how these influential factors may play a role in medical 
decision-making, rather than providing a complete review of all possible decisional 
influences. Specifically, research on medical decision-making emphasizes the influence 
of characteristics of the patient, the decision itself, the physician, and the manner in 
which information about the decision is presented (See Table 2 below). 
Table 2 
Salient Decisional Influences 
 
 
Decision 
 
 
Presentation  
 
   
Patient 
 
Provider 
 
Magnitude 
 
 
Framing of Risks & 
Benefits 
 
 
Belief System/ 
Culture/ 
Demographic 
Characteristics 
 
 
Presentation Style 
Time to Decide Presentation of 
Numbers 
Competency/ 
Literacy/ Education 
Confidence in 
Treatment or 
Recommendation 
 
Continual versus     
Discrete 
Quantity of 
Information 
 
Decision Specific 
Knowledge 
Motivational Factors 
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Reversibility Rationale Heuristic tendencies 
/Emotions 
 
Available Evidence  
 
Many patients who are presented with an ICD choice are facing the reality of 
their mortality for the first time.  As this news may be alarming, patient involvement in 
medical decision-making can vary considerably. When patients do take time to fully 
consider the pros and con of a decision, this is labeled as “systematic processing” 
(Chaiken & Maheswaran, 1994). When a patient is limited in their willingness or ability 
to process information, heuristic tendencies (Tversky & Kahneman, 1974) may guide 
decisions more strongly. For example, some patients do not want to make shared 
decisions, often preferring that the doctor make the final call (Robinson & Thomson, 
2001). This reliance on the physician has been labeled as the “expert opinion heuristic” 
(Chaiken, Liberman, & Eagly, 1989). In addition, the availability heuristic (Tversky & 
Kahneman, 1974) is potentially problematic for patients as their prediction of the 
frequency of an event is based on how quickly one comes up with an example. If a 
patient readily thinks of a person who experienced frequent shocks or thinks of a device 
recall attorney commercial, bias may inordinately lead the decision maker to a particular 
decision. When heuristics are used in medical decisions, patients may choose without 
full understanding of the facts. Heuristics have differential influence, as there is a partial 
influence from (a) social norms, habits, and other personal characteristics and (b) the 
framing of the decision (Tversky & Kahneman, 1981).  
A patient’s personal characteristics have a varying influence on their ultimate 
health decision (Tercyak et al., 2001). Research suggests that men have a greater 
tendency toward reliance on physician advice (Arora & McHorney, 2000).  Other 
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characteristics associated with reliance on expert opinion heuristics include: patients 
who are older (Arora & McHorney, 2000; Ende, Kazis, Ash, & Moskowitz, 1989), lower 
cognitive abilities (Cutilli, 2007; Vellinga, Smit, Van Leeuwen, Van Tilburg, & Jonker, 
2004), lower literacy (Cuculi, Herzig, Kobza & Erne, 2006), lower education level (Arora 
& McHorney, 2000) and less decision specific knowledge (Damasio, 1994). By placing 
total trust in the physician, patients are less likely to take an active role in their future 
healthcare (Anderson & Dedrick, 1990), and this external locus of control is frequently 
detrimental toward positive health-related choices (Trento et al., 2008).  
One study examined the decision-making styles of those who must make 
treatment decisions for heart failure. Two groups were distinguished and labeled active 
(55%) and passive (45%) decision makers. The study evaluated decision-making 
among 22 patients using descriptive theme analysis in an iterative process to analyze 
responses to the question: "Can you tell me about any important or difficult decisions 
you have had to make about your heart condition?"  Those who used an active 
decision-making style identified interventions including ICDs, medications, and 
transplants to be difficult decisions. Active decision makers cited concerns for side 
effects, family, and quality of life as factors that carry weight in these treatment 
decisions. Those with passive decision-making styles did not typically identify a difficult 
decision and reported factors such as trust in God, trust in the physician, and power of 
the physician as reasons for being passive (Matlock, Nowels, & Bekelman, 2010).  
In some circumstances, such as when patients endorse religious health fatalism, 
providers may have minimal influence on treatment decisions (Franklin, Schlundt, & 
Wallston, 2007) and while some aspects of religiosity are often associated with the 
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promotion of health, religious health fatalism may be associated with poorer health 
outcomes (Caplan & Schooler, 2003; Powe & Finnie, 2003). This reliance on, or faith in 
the doctor, has been demonstrated as relevant in more severe medical illnesses, such 
as choice of cancer treatment (Patel et al., 2002; Roberts, Brown, Elkins, & Larson, 
1997). In general, patients who are involved in reaching a treatment decision report 
increased satisfaction, reduced decisional conflict, and improved compliance with 
treatment (Anderson et al., 1995; Jahng, Martin, Golin, & DiMatteo, 2005). 
Since providers can have a strong influence on patient choice for treatment by 
way of their recommendations, the manner in which risk and benefit information is 
framed is important. For example, patients may choose a variety of treatments more out 
of fear of consequences than they do the potential benefits (Sedgwick & Hall, 2003). 
Most patients are more affected by risks than benefits, as they overestimate the 
likelihood of risks (Alaszewski & Horlick-Jones, 2003), because emotional aspects can 
impact decisions for which they are not experts (Damasio, 1994).  
The ICD decision is unique because it is a major life decision that must be made 
in a relatively short time period and, since implantation is not easily reversible, changing 
one’s mind is not always a reasonable option. When a lack of awareness to potential 
biases in decision-making exists, the process of provision of education information for 
potential ICD recipients may not be optimally effective. Because there are health and 
psychosocial risk factors regardless of the patient’s decision, adjustment to life with an 
ICD relies, to some extent, on the ability of healthcare providers to provide patients with 
appropriate information and guidance. Some researchers (Lewin, Coulton, Frizelle, 
Kaye, & Cox, 2007; Sears, Shea, & Conti, 2005) have asserted that prospective ICD 
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patients need information on the functioning of their device, the possibility of device 
recall, the clarification of possible changes in daily activities, and guidance on planning 
for shock. While it may be true that this information is important for patient success, the 
information may only be presented from the point of view of what providers believe is 
relevant to patient success based on their own experiences.  This process may 
underrate the salience of specific factors from the patient’s perspective. 
The manner in which providers interact with prospective ICD patients may 
influence patient choice, and patient characteristics may influence how providers 
present information. Despite similar rates of SCD, initial research in this area suggests 
that the ICD is more likely to be recommended to elderly and male patients (Lin et al., 
2008) and black and female patients are more likely to refuse recommendations 
(Hernandez et al., 2007). Others have shown that geography plays an important role, 
which is closely related to racial disparity in those who are offered the device in various 
regions (Groeneveld, Matta, Suh, Feifei Yang, & Shea, 2007; Thomas, Al-Khatib, 
Kelsey, Bush, Brosius, Velazquez, et al., 2007). These disparities remain, even after 
controlling for differences in incidence and severity of disease (Peterson et al., 1997), 
access to healthcare (Giles, Anda, Casper, Escobedo, & Taylor, 1995), health 
insurance (Carlisle, Leake, & Shapiro, 1997), financial incentives for doctors (Whittle, 
Conigliaro, Good, & Lofgren, 1993), and clinical indications (Conigliaro et al., 2000). 
Other explanations for these differences have been asserted, such as bias in treatment 
recommendations (van Ryn, 2002) and variation in patients’ willingness to accept 
recommendations (Gordon, Paterniti, & Wray, 2004; Whittle, Conigliaro, Good, & 
Joswiak, 1997).  
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ICD patients tend to be composed of a more elderly population, which may mean 
potential recipients prefer their doctor to make the decision for them. In fact, for many 
prospective ICD patients, there is a general reliance on their doctor’s advice (Agard, 
Lofmark, Edvardsson, & Ekman, 2007) as is consistent with other research for such a 
complex and life changing decision. Those who are approached about ICD placement 
tend to be older in age, which lends more problems with competency and other 
cognitive issues. Potential literacy gaps may also prevent full understanding of a 
decision and may be especially problematic with the high degree of sophistication 
inherent in the ICD. Many patients are not particularly knowledgeable about the ICD, 
and without appropriate education, patients may simply rely on their providers for their 
decisions. 
Patient factors such as demographics, the emotional content of the decision, 
cognitive abilities, and heuristic tendencies should be considered when providing risk 
and benefit information. While physician reliance for decisions may be seen as a 
problem, the intent of the current research is not to prevent this phenomenon.  Rather, 
the goal is to understand what information patients deem relevant in making their 
decision, rather than subjecting them to an excessive range of information that they may 
not process fully or appropriately. Decision analysis is often used in research to 
examine and clarify relevant factors in decision-making. 
Decision Analysis 
Decision Analysis is a scientific approach to examining and clarifying the 
influences on decision-making. This process has been studied in various fields of 
research such as economics, law, political science, organizational science, and medical 
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informatics. As such, there are a number of theoretic approaches and philosophies to 
studying decision processes. Decision analysis is typically viewed as the use of various 
procedures, methods, and tools for identifying, clearly representing, and formally 
assessing the important aspects of a decision situation. While normative or rational 
models of decision making do not account for the irrational or unexpected choices 
humans make, descriptive models recognize that the correct or gold standard may differ 
significantly between individuals. Regardless of theoretical orientation, the typical goal 
of decision analysis is to remove ambiguity from choice and focus attention on the 
uncertainties that may change or impact one’s decision. The use of decision analysis in 
medical settings often comes in the form of decision aids, which may help medical 
patients make informed choices (O'Connor et al., 2001).  
Significant controversy exists in the literature as to whether the theoretical 
underpinnings of decision tools fully and accurately represent the “real world” decisions 
of patients (Patel et al., 2002; Shafir & LeBoeuf, 2002). The current research attempts 
to address this issue by not prescribing a correct decision. Instead, the current research 
aims at addressing aspects of the decision that are important to the patient, prior to 
providing any additional education on the risks and benefits of their choice.  
Decision research in medical settings has primarily focused on two objectives: (1) 
understanding how decisions are made by healthcare providers and patients and (2) 
developing ways to make the decision process better.  The importance of these 
objectives is evident when considering the variability in how patients adjust to their life 
with an ICD. Patient acceptance (Burns, Serber, Keim, & Sears, 2005) has been 
defined as the adjustment to living with an ICD. This concept is important to the current 
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study because, theoretically, patient acceptance is partly the result of the quality of a 
patient’s decision. 
The clinical importance of understanding the decision-making process is 
reflected in recent ICD-related decision-making research. In a study among 19 patients 
with an ICD, approximately 50% indicated that they would have their device deactivated 
if their condition were to decline; however, only 2 of these individuals recalled having 
had a discussion about this choice with their physicians (Habal, Micevski, Greenwood, 
Delgado, & Ross, 2011). This study by Habel and colleagues suggests that at least 
some providers may not engage with patients in discussions of important ICD decision 
before or after implant. Additional research has examined decision-making related to 
sports participation in youth with pacemakers and/or ICDs, suggesting that patients 
continue to weigh the pros and cons of the device even after implant (Beery, Smith, 
Kudel, & Knilans, 2011).  
 The goal of analyzing patient ICD decision-making processes are to improve the 
educational procedures by laying a foundation for pre-implant assessment, providing 
assistance in making a quality ICD-related health decisions, and thereby, attempting to 
prevent post-implant difficulties. Although previous research has documented a variety 
of positive and negative perceptions about the ICD, no studies are available which 
address the ICD decision by a decision analysis approach. Figure 1 depicts how the 
current study is the initiation of a relatively new line of psychosocial research among the 
ICD patient population.  
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To help patients make informed choices, decision analysis will be utilized in this 
patient population. However, theory must be utilized in order to analyze the specific 
decision with which potential ICD must contend.   
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Figure 1 
Graphical Representation of ICD Decision Analysis 
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Application of Theoretical Models 
 The application of theory provides researchers the ability to specifically target the 
multidimensional fundamentals of a behavior (Rothman, 2004).  Without acknowledging 
these fundamentals, researchers may not be able to fully indentify the factors that are 
important in patients' decisions as to whether or not they choose the ICD. 
The Biopsychosocial-Spiritual Model 
The following is a review of commonly cited risks and benefits of the ICD, 
followed by important cognitive, emotional, and social factors that influence decision-
making processes. The research literature examining ICD patient decision-making 
reveals few direct reasons why some ICD indicated patients choose implantation, while 
others patients do not. However, the literature provides a number of benefits and 
consequences of getting an ICD, which may be considered in ICD decision-making.  
Most health psychology research organizes risks and benefits by use of the 
Biopsychosocial Model (Engel, 1977). This model was constructed to account for the 
missing role of the patient in the biomedical mode (Engel, 1980). From a biomedical 
perspective, choosing the ICD would almost always represent the “correct choice.” 
However, when considering quality of life, the impact on social relationships, and 
spiritual/existential beliefs, the “correct choice” is not always as clear. Providing 
intervention that is tailored and theoretically informed by the biopsychosocial model is 
not currently part of medical standard practice for prospective ICD patients.  Although 
efforts have been made in specifying connections between biological, psychological, 
and social processes in the ICD literature, the full potential of the Biopsychosocial 
Model in health care has not been fully utilized. In a more recent review of Engel’s 1997 
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model by Suls and Rothman (2004), they recommend that to better utilize this model 
research must continue to seek to understand and utilize linkages among biological, 
psychological, social, and macrocultural variables. The present research applied a 
Biopsychosocial-Spiritual Model, with the spiritual component representing the 
macrocultural component asserted by Suls and Rothman (2004).  
The Biopsychosocial-Spiritual Model may be a more holistic perspective with 
which to conceptualize patients whose treatments relate to life versus death (King, 
2000; McKee & Chappel, 1992). Previous research suggests that spirituality might be 
an important aspect of the quality of life (QOL) of cancer patients (Brady, Peterman, 
Fitchett, Mo, & Cella, 1999). This study examined 1610 patients from an ethnically 
diverse sample and found that a measure of spirituality was found to be significantly 
associated with QOL to the same degree as physical well being, and the association 
between spirituality and QOL was unique, remaining after controlling for core QOL 
domains as well as other possible confounding variables. Furthermore, spiritual well-
being was found to be related to the life enjoyment in the presence of medical 
symptoms. The authors suggested that the spiritual domain might be an important 
clinical target. While spiritual may be an important domain considering the life 
threatening context of the ICD decision, there is limited evidence that incorporates 
spirituality in the ICD patient population. 
Biological/Medical Considerations for the ICD. Biomedical pros and cons are 
the factors that receive the most attention by both providers and patients.  Improved 
survival stands as the most recognized benefit of the ICD; clinical trials have 
demonstrated the ICD as the primary treatment option for the prevention of sudden 
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cardiac death based on clinical trial data (Bardy et al., 2005). A simple principle for at 
risk patients might be: The sooner an ICD is received, the better. The only exception to 
this principle is the acute myocardial infarction patient who has ongoing mortality risk 
secondary to ischemic management, consistent with the DINAMITE trial. Patients at risk 
for SCD face a significantly increased chance of death each year without an ICD 
compared to that of ICD recipients (Koller et al., 2008). Therefore, providers and 
patients may discount the complete set of risks of an ICD since they have known risk of 
SCD that is potentially being offset.  The most relevant cons include surgical and 
infection risk (Klug et al., 2007), inappropriate and appropriate shock (Daubert et al., 
2008; Poole et al., 2008; Vollmann, Luthje, Vonhof, & Unterberg, 2005), device recalls 
(Gibson, Kuntz, Levenson, & Ellenbogen, 2008; Maisel et al., 2006), and 
electromagnetic interference (Barbaro et al., 1999; Gimbel & Cox, 2007; Occhetta, 
Plebani, Bortnik, Sacchetti, & Trevi, 1999; Shellock, Tkach, Ruggieri, & Masaryk, 2003; 
Tandogan et al., 2005; Yerra & Reddy, 2007). 
Risk of death during implantation is a reasonable initial concern, although this 
risk is very low, occurring in less than 1% of patients. Other rare risks associated with 
implantation include swelling, bruising, bleeding, or infection in the area of implantation. 
There is also potential for a collapsed lung or blood vessel, heart, or nerve damage from 
procedural complications. Additionally, some patients may react negatively to the 
anesthesia used in surgery; however, this is a reversible effect. Implantation also tends 
to leave some degree of scarring and a bulge from the ICD. While the ICD has been 
shown to correctly detect arrhythmias 99% of the time, the device still has some 
limitations in its ability to terminate all arrhythmias (Klug et al., 2007). 
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Shocks that occur due to arrhythmias that are not necessarily life threatening are 
often referred to as “inappropriate shocks.”  For example, patients in atrial fibrillation are 
often asymptomatic (meaning that they do not perceive the fibrillation occurring), and 
their condition is not immediately life threatening. In this scenario, the ICD may apply 
shock because of atrial oversensing when the shock is not necessarily needed. Recent 
research indicates that inappropriate shocks remain a significant problem with 11.5% of 
primary prevention patients receiving one or more shocks and those episodes 
amounting to 31.2% of all shock episodes (Daubert et al., 2008).  Inappropriate shock 
may lend a small risk for death (Poole et al., 2008; Vollmann et al., 2005), but there is 
insufficient evidence to claim a consequent of the device is that inappropriate shock can 
lead to death. In any case, devices can be reprogrammed and medication regimens can 
be altered to help prevent shocks from occurring inappropriately; however, shocks 
(appropriate or inappropriate) cannot be eliminated altogether. 
Over the last few years, many of the leading device manufacturers have 
experienced a US Food and Drug Administration recall or advisory indicating a 
significant problem with the device (Gibson et al., 2008). As in all biomedical 
technology, recall is an ongoing threat, but with the ICD, recall has not been a common 
problem.  However, reports show that ICD replacement resulting from device 
malfunction increased by both number and rate between 1996 and 2002 (Maisel et al., 
2006). In 2007, Medtronic Incorporated posted an online advisory letter that reported 
data indicating an estimated 3% per year fracture/failure of their Fidelis leads (Medtronic 
Inc., 2007).  Until the Medtronic Fidelis recall, device recalls were seen as extremely 
rare with the highest estimates at .0268% of patients having hardware flaws such as 
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battery problems or electrical problems (Maisel et al., 2006). While actual overall recall 
numbers remain low, decreased utilization of the device may be a result. Specifically, a 
media advertised recall might have a strong influence on a potential recipient’s choice of 
treatment for an ICD (Cuculi et al., 2006). Clearly, negative perceptions are increased 
by these events and the resulting media coverage. 
Electromagnetic interference is another potential concern and can result from 
any high powered electric or magnetic signal that obstructs the functioning of the ICD 
(Yerra & Reddy, 2007), such as security systems (Gimbel & Cox, 2007), medical 
imaging (Shellock et al., 2003; Yerra & Reddy, 2007), or cellular phones (Barbaro et al., 
1999). Most experts agree that MRI is a contraindication for patients with ICDs because 
of the potential to disturb programming and heat the elements of the ICD (Shellock et 
al., 2003; Yerra & Reddy, 2007). Recent research suggests that there does not seem to 
be any interference from wireless communication devices (Tandogan et al., 2005). It is 
recommended that patients with ICDs not carry or place an active digital cellular 
telephone within 6 inches of the device (Occhetta et al., 1999). Fortunately, due to the 
improved technology of the modern ICD, such interferences are now quite uncommon 
(Yerra & Reddy, 2007).  
Critical events surrounding the use of the ICD include device implant, ICD shock 
events, device recalls, and end of life issues. For example, regarding end of life, 
patients can be shocked at the time of death resulting in a non-peaceful death. Clinical 
management of these critical events has been suggested that includes patient 
education, provision of psychosocial information, activity prescriptions, recall planning, 
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and shock planning (Sears, Matchett, & Conti, 2009). These critical events exemplify 
the connection between biomedical and psychosocial considerations for the ICD.  
Psychosocial Considerations for the ICD. While many patients report a sense 
of security due to the protective qualities of the device (Lemon & Edelman, 2007), a 
substantial minority experience significant difficulties with anxiety (Burke, Hallas, Clark-
Carter, White, & Connelly, 2003; Dougherty, 1995; Hamner, Hunt, Gee, Garrell, & 
Monroe, 1999; Irvine et al., 2002; Kuck, Cappato, Siebels, & Ruppel, 2000a; Luderitz, 
Jung, Deister, & Manz, 1994; Namerow et al., 1999; Neel, 2000; Passman et al., 2007; 
Pedersen, van Domburg, Theuns, Jordaens, & Erdman, 2004; Sears, Todaro, Lewis, 
Sotile, & Conti, 1999; Sears & Conti, 2002;  Sears et al., 2007; Shemesh et al., 2006; 
Sowell, Sears, Walker, Kuhl, & Conti, 2007; Stutts et al., 2007), depression (Bilge et al., 
2006; Carney & Freedland, 2003; Goodman & Hess, 1999; Luyster, Hughes, Waechter, 
& Josephson, 2006;  Sears et al., 1999;  Sears & Conti, 2002; Whang et al., 2005), and 
a poorer quality of life (QoL) when patients begin to limit their activities or have an 
unhealthy focus on their cardiac disease (Finch, Sneed, Leman, & Watson, 1997; 
Francis, Johnson, & Niehaus, 2006; Passman et al., 2007; Prudente, 2005; Schron et 
al., 2002;  Sears et al., 2000;  Sears et al., 2006; Steinke et al., 2005). Some recipients 
of the ICD appear to be predisposed to experience adverse psychosocial outcomes. 
Patients who experience adverse psychosocial outcomes may have risk factors such as 
younger age (<50 years of age), female sex, having experienced shock in the past, or a 
pre-morbid psychiatric history that predispose them to having greater psychological 
issues following the distress of ICD implantation (Sears & Conti, 2003).  
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Psychological distress among ICD recipients is influenced by pre-morbid 
conditions, such as inadequate social support, deficits in physical functioning, and a 
history of psychological distress (Luyster et al., 2006). Recent research has explored 
how personality factors might influence outcomes among recipients of ICDs. Patients 
with Type D or “distressed” personalities are those who display negative affect and have 
trouble communicating their emotions. Those with such personalities have been 
identified as being at risk for poor psychosocial outcomes (Pedersen & Denollet, 2003; 
Pedersen et al., 2004). While psychosocial morbidity can be a precursor of device 
implantation, research indicates that living with the device can exacerbate or ignite 
psychological distress, low treatment satisfaction, and poorer treatment outcomes 
(Ladwig, Deisenhofer, Simon, Schmitt, & Baumert, 2005).  
As noted above, anxiety is a considerable consequence of the ICD, with 13-38% 
of ICD patients experiencing symptoms (Burke et al., 2003; Sears et al., 1999; Sears & 
Conti, 2002). Anxiety in ICD patients may be due in part to the fear of potential shock 
(Connolly et al., 2006), device recall (Stutts et al., 2007), or a general fear of death due 
to their condition (Pauli, Wiedemann, Dengler, Blaumann-Benninghoff, & Kuhlkamp, 
1999). Several studies have shown that as number of shocks increase, adjustment 
difficulties also rise (Irvine et al., 2002; Kuck et al., 2000; Luderitz et al., 1994; Namerow 
et al., 1999). PTSD rates among ICD patients have been reported as approximately 
20% (Kapa et al., 2010; Ladwig et al., 2008; Sears, Hauf, Kirian, Hazelton, & Conti, 
2011) which is plausible with the potential of unpredictable and aversive shocks 
(Hamner et al., 1999; Neel, 2000). Interestingly, spouses often experience more anxiety 
and distress than recipients themselves, as a result of device implantation and shock 
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experienced by their significant other (Dougherty, 1995; Pedersen et al., 2004; Sowell et 
al., 2007). A study by Keren and colleagues (2011) found no differences between 
patients at risk of a lead recall compared to controls; however, patients who had 
experienced a lead fracture had greater anxiety and depression scores compared to 
control patients. The psychological morbidity was primarily related to inappropriate ICD 
shock rather than recall.  
Significant problems with depression have in fact been documented as well, 
occurring in 24-41% of ICD patients (Bilge et al., 2006; Sears et al., 1999). Depression 
may be common because these patients experience actual and perceived losses or 
limitations in social functioning (Goodman & Hess, 1999), ability to engage in preferred 
activities (Lemon & Edelman, 2007), and physical functioning (Kohn, Petrucci, Baessler, 
Soto, & Movsowitz, 2000). Depression can be especially debilitating because it may 
affect mortality, morbidity, and cardiovascular symptoms by weakening a patient’s ability 
to properly cope and manage their disease (Carney & Freedland, 2003). Depression 
may also arise from the knowledge of having a greater risk for sudden cardiac death 
(Sears & Conti, 2002). Also, ICD patients may experience a type of “learned 
helplessness” as more shocks may lead to greater levels of depression and anxiety 
(Goodman & Hess, 1999). Moreover, issues such as device recall may also contribute 
to a patient’s feelings of helplessness as well. The Triggers of Ventricular Arrhythmias 
Study (TOVA) established in initial assessments of 645 ICD patients that approximately 
18% were depressed, with more severe levels of depression related to increased 
frequency of shock longitudinally (Whang et al., 2005), which may suggest a dose 
response relationship between the frequency of shock and level of depression.  
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QoL is often adversely affected by shock (Schron et al., 2002), as seen in 
patients whose fear of ICD shock prevents them from engaging in preferred activities 
such as sexual (Steinke et al., 2005) or other physical activities (Sears et al., 2000). 
Additionally, temporarily losing one’s privileges to drive after receiving ICD shock 
negatively impacts quality of life for many patients (Finch et al., 1997). A recent meta-
analysis reported that quality of life remained the same in a majority of patients 
receiving an ICD; however, the greater part of these randomized studies found that 
patients receiving shocks experienced worsening QoL (Francis et al., 2006). An 
analysis demonstrated that there is no evidence to suggest that patients receiving an 
ICD for primary prevention have subsequent poorer QoL or greater distress than 
patients receiving an ICD after cardiac arrest (Pedersen, Sears, Burg, van den Broek, 
2009). More recently, research has found that the experience of even one ICD shock 
decreases QoL in recipients, but clinically significant deficits do not appear to occur until 
the experience of 5 or more device discharges (Passman et al., 2007).  
Spiritual/Existential Considerations for the ICD. Shock and shock storm (i.e., 
receiving 5 or more shocks within 24 hours) also play a large role in a patient’s quality of 
death (Poole et al., 2008). This concept has come to light in recent ICD literature as 
failure to deactivate the device may cause shock at the time of death, resulting in a non-
peaceful death (Sears et al., 2006). Quality of death emphasizes that there are factors 
that are important to ICD patients beyond the difficulties associated with a diagnosis of 
heart dysfunction or experiences such as shock or device recall.  
Spirituality has been mentioned as an important consideration among ICD 
patients since an article by Ocampo (2000) described the need of a shift in focus from 
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evaluating biomedical outcomes of ICD treatment to an evaluation of the emotional, 
spiritual, and psychological variables. A study reported that ICD patients in the United 
States reported significantly higher psychological-spiritual satisfaction than Swedish 
patients both before and after ICD implantation (Bolse et al., 2002). Not only are there 
spiritual differences between diverse ICD samples, but also, spiritual quality of life has 
been shown to decrease in the first year after ICD implant (Flemme, et al., 2005). In a 
more recent study (Bolse, Johansson, & Stromberg, 2010), researchers examined the 
educational materials and discussions provided to ICD patients and found that biological 
information was predominant. Emotional, intellectual and socio-cultural dimensions 
were rarely provided, and there were not references or discussions related to the 
spiritual-existential domain.  
Presumably, the previously mentioned device-related pros and cons influence 
patients in different ways and to varying degrees, affecting choice of the device, as well 
as adjustment to life with a device. It is clear that the pros and cons of the ICD are 
numerous. Patients must consider the factors in the ICD decision and somehow make a 
significant life decision.  
Once the ICD has been medically indicated, patients’ choices for or against the 
device may be based on correct perceptions, but also may be based on misperceptions. 
These misperceptions prevent understanding of the potential negative (e.g., aversive 
shock) or positive (e.g., prolonged life expectancy) effects of their choice. Health 
behavior models such as the Transtheoretical Model (Prochaska & Velicer, 1997), the 
Health Belief Model (Janz & Becker, 1984), and the Theory of Planned Behavior (Ajzen 
& Fishbein, 2005; Ajzen, 1991), emphasize how beliefs may play an important role in 
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the decision to perform health-related behaviors. These theories emphasize that 
decisions are affected by the cognitive and social contexts of a decision.  
The Transtheoretical Model 
The Transtheoretical Model of Change provides an excellent framework for 
understanding how patient weigh pros and cons (Prochaska & Velicer, 1997).  An 
individual’s weighing of advantages (pros) and disadvantages (cons) has been termed 
“decisional balance” (Janis and Mann, 1977; Velicer, DiClemente, Prochaska, & 
Brandenburg, 1985). The Transtheoretical Model of Change emphasizes five stages of 
change: pre-contemplation, contemplation, preparation, action, and maintenance. 
Those making decisions in the Transtheoretical Model of Change can move back and 
forth between the specific stages. Patients faced with the ICD decision cannot step back 
toward previous stages once the device is implanted, because the procedure is not 
easily reversible and patients face considerable risk in order to have the ICD removed. 
However, this model describes how an individual is capable of making a behavior 
change decision only if they have begun contemplating the pros and cons of their 
current thoughts and behaviors. This theory has been useful in the initiation of many 
health behaviors as individuals are aided in specific health decisions (Prochaska et al., 
1994). Some of the most successful uses include decreasing alcohol use (Migneault, 
Velicer, Prochaska, & Stevenson, 1999) and smoking cessation (Lafferty, Heaney, & 
Chen, 1999). Prior to their “final” decision, those who are indicated for an ICD have a 
limited time to weigh the pros and cons of the ICD, and their perceptions and beliefs 
about their condition and the protective ability of the ICD may influence their decision. 
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The Health Belief Model provides valuable rational for attempting to understand the 
beliefs on these pros and cons on patient choice. 
The Health Belief Model 
The Health Belief Model (Rosenstock, 1990) focuses on people’s attitudes and 
beliefs in an attempt to explain and predict their health behaviors. The Health Belief 
Model been adapted to explore a variety of health behaviors, such as sexual risk 
behaviors (Zimmerman & Olson, 1994) and breast self-examination (Norman & Brain, 
2005). The model has also been applied to health decisions similar to that of the ICD 
choice, such as medical imaging for various health conditions (Ludwig & Turner, 2002). 
In a study about health beliefs regarding medical imaging, a survey of 200 participants 
found that less than half of responders agreed with experts regarding the low risk of 
radiation exposure from various sources. The Health Belief Model is based on the 
understanding that a person will take a health-related action (i.e., choose the ICD) if that 
person feels that a negative health condition (i.e., SCD) can be avoided, has a positive 
expectation that by taking a recommended course of action a negative health condition 
will be avoided (i.e., the ICD will be effective at preventing SCD), and believes that a 
recommended health action can be taken on with success (i.e., use of the ICD will 
produce confidence in choice and a higher quality of life). 
Despite the important role of beliefs in the ICD decision, the Health Belief Model 
does not assess the intent of a patient to choose or not choose the ICD. Behavioral 
intent was utilized in the present study because an actual medical decision is not 
uniformly made at the time of a particular visit with their physician. Behavioral intent of 
ICD choice, rather than actual ICD choice, is the construct that is subsequently 
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described in this manuscript. Due to the wide range in medical severity, some patients 
may be forced into an immediate decision, while others may go home to contemplate 
their decision. Therefore, planned behavior was the closest proximity to actual choice 
that could be uniformly assessed across patients. 
While there appears to be no theory that fully accounts for all influences on 
patient decision-making for or against an ICD, the Theory of Planned Behavior provides 
the theoretical underpinning for the current study by describing how patients plan to 
make health decisions. The Transtheoretical Model of Change describes how decisions 
might be influenced by a variety of pros and cons, and the Theory of Planned Behavior 
describes how factors beyond the actual pros and cons receiving an ICD. The 
discussions of these health-related decision-making models provide evidence that the 
beliefs of a potential ICD recipient are critical elements in decision-making.  
The Theory of Planned Behavior 
With behavioral intent in mind, the Theory of Planned Behavior (Azjen, 1991) is a 
model that was most applicable to the present study. This model asserts that behavior 
is led by "behavioral beliefs," "normative beliefs," and "control beliefs." When an 
individual’s “attitude toward the behavior” and the “subjective norm” are positive, and 
his/her “perceived behavioral control” is strong, the stronger the person’s intention to 
engage in a particular behavior will be. If there is sufficient “actual behavioral control,” 
individuals tend to engage in the behavior if the situation presents (Ajzen & Fishbein, 
2005). The model has been applied to healthcare, and these studies have 
demonstrated improvement in the prediction of behavioral intentions such as with 
condom use (Albarracin, Fishbein, Johnson, & Muellerieile, 2001), exercise (Nguyen, 
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Potvin, & Otis, 1997), and diet (Conner, Kirk, Cade, & Barrett, 2003). A primary 
consideration when assessing planned behavior is acknowledging that this is not an 
actual ICD decision; however, Azjen and Fishbein (1980) note that the more factors that 
can be addressed/assessed in a measure of conditional intention, the better the 
measure’s ability of predicting future behavior. They also indicate that specifying a 
condition (e.g., if your doctor recommends the ICD) increases the likelihood that intent 
will be highly related to the behavior. By adding the multidimential aspects of the 
Biopsychosocial-Spiritual Model as components of a measure of conditional intent of 
ICD choice, the intention behavior gap would theoretically be reduced. 
Unfortunately, these models do not specify how to identify relevant beliefs that 
influence decisions. Decisional tools can assist patients in receiving tailored information 
about the ICD, and they may therefore move toward an action related to the ICD with 
more knowledge and confidence. A recent review by Mulsow Feeley, and Tierney 
(2011) describes how most surgical patients generally have a limited understanding of 
the procedures and possible outcomes of many procedures. They also describe the lack 
of data to support the use of educational handouts, but they report that patients with 
lower educational levels may gain most from additional interventions. Decision aids on 
the other hand are routinely used with patients making decisions regarding breast 
cancer treatments. A recent review of breast cancer decision aids by Belkora and 
colleagues (2011) reported that there are significant gains in knowledge and reductions 
in decisional conflict. Again, those with the lowest knowledge appeared to profit the 
most from these interventions. Decision analysis is needed to indentify the relevant 
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beliefs related to the ICD decision so that a theory informed and empirically validated 
ICD decision tool can be effectively implemented. 
Summary 
The most effective treatment and preventative measure of sudden cardiac arrest 
(SCA) is the Implantable Cardioverter Defibrillator (ICD). ICD Indication is fairly 
straightforward for most patients who have experienced an episode of SCA. Despite the 
efficacy of the ICD in a number of large-scale studies and clear indication guidelines 
(Epstein, 2008), patients who are offered the opportunity to receive an ICD do not 
always elect to do so. Unfortunately, many patients do not have the time, 
understanding, or ability to process the pros and cons of the ICD, and decisions made 
on a lack of information may not be desirable. Researchers and clinicians have no 
empirical method of assessing the factors that patients consider in this important 
medical decision. Because ICD technology is complex and choice is influenced by a 
variety of factors, assisting patient in ICD decision-making is a matter of improving 
educational procedures for prospective ICD Patients. Decision analysis for medical 
treatments has been utilized in various medical decisions; however, there are practically 
no assessments or interventions for patients who are in the decision-making phase 
regarding the ICD choice.  The Biopsychosocial-Spiritual Model helped lay a framework 
for ICD pros and cons and the Transtheoretical Model was reviewed because the 
approach provides a rationale for systematically accounting for the pros and cons of 
ICD treatment. Given the practical limitation of assessing patients who may or may not 
be asked to make a decision at the time of recruitment, the Theory of Planned Behavior 
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was considered to provide a coherent reason for assessing the conditional behavioral 
intent of ICD choice.  
Present Study 
The objective of this project was to take a first step into creating an empirically 
validated decision aid to improve ICD decision-making.  To achieve this objective, the 
goal was to design a measure assessing the importance of various ICD 
biopsychosocial-spiritual pro and con factors that may influence ICD decision-making by 
examining the set of factors that have weight in the decisional balance of the ICD. We 
also wanted assess the predictive validity of the proposed ICD measure (i.e., 
Implantable Cardioverter Defibrillator – Decision Analysis Scale) on behavioral intention 
to receive the ICD. While providing an opportunity for patients to rate the most 
personally salient pros and cons, practitioners can quantitatively assess the patients’ 
perceptions of risks and benefits of the device. As patients weigh pro/con items in a 
variety of ways, information can be given that targets their specific concerns and/or 
misperceptions. This will offer a higher standard of patient care by providing the most 
comprehensive educational information, while also allowing for more personalized 
intervention to be undertaken prior to and following implantation, should that choice be 
made.  
Assessments of each patient’s biological, social, psychological, and spiritual 
domains were considered necessary as the literature review provided examples of 
important considerations for each of these domains. For purposes of discriminative 
validity, comparisons between the ICD-DAS and other psychosocial measures that 
could represent each of the tenets of the Biopsychosocial-Spiritual Model was also 
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considered necessary. The Medical Outcomes Study-Short Form-12 Health Survey (SF-
12), provides physical quality of life scores, tapping into the biological tenet of the 
Biopsychosocial-Spiritual Model, while also provides a measure of psychological quality 
of life (Ware, Kosinski, & Keller, 1996). The Hospital Anxiety & Depression Scale 
(HADS) (Zigmond & Snaith, 1983) assesses depression and anxiety, tapping into the 
psychological tenet of the Biopsychosocial-Spiritual Model. Form C of the 
Multidimensional Health Locus of Control (C-MHLC) scale (Wallston, Stein, & Smith, 
1994) assesses beliefs about how decisions are made in terms of factors in one’s 
personal control and factors outside of one’s own control. This measure taps beliefs 
about the influence of social and, to some extent, on spiritual domains in one’s life when 
considering this measure’s assessment of “powerful others.” The Religious Health 
Fatalism Questionnaire (RHFQ) (Franklin et al., 2008) assesses fatalistic religious 
beliefs, tapping into the spiritual tenet of the Biopsychosocial-Spiritual Model. 
Specific Aims 
The first aim was determining a set of pros and cons of getting an ICD and using 
these items as variables in an ICD-related measure. More specifically, part 1 of the 
study sought to compile the risks and benefits of the ICD by way of a review of the 
literature and expert review of the items, and the conclusion of part 1 was 
accomplishing the initial design of the Implantable Cardioverter Defibrillator – Decision 
Analysis Scale (ICD-DAS).  
The second aim was to measure the importance of pro/con perceptions in 
relation to the conditional behavioral intent of choice of the ICD. Behavioral intent was 
measured by asking patients, “If your doctor recommended an ICD, how likely would 
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you be to get one?” A sub-aim of the part 2 of the study was to analyze associations 
between the ICD-DAS, the behavioral intent to choose an ICD, and the additional 
psychosocial measures, socioeconomic variables, and demographic variables. 
Hypotheses 
While the current study was exploratory, there was an expectation that factor 
analysis would reveal a 4-factor solution, with a biological component, a psychological 
component, a social component, and a spiritual/existential component. This hypothesis 
was expected due to the theoretical underpinning of this study, as a 4-factor solution 
would represent each of the 4 tenets of the Biopsychosocial-Spiritual Model. Regarding 
discriminative validity, it was hypothesized that the ICD-DAS would better predict 
behavioral intent to choose the ICD than a standard set of psychosocial measures 
representing biological, psychological, social, and spiritual/existential domains. This 
prediction was based on the premise that the ICD-DAS would be more tailored by 
containing ICD-specific information. It was also predicted that African American 
participants would be less likely to have behavioral intent to choose the ICD and have 
higher scores on religious health fatalism. This prediction was based on research that 
has shown higher rates of ICD refusal among African American patients (Hernandez et 
al., 2007) and research that has shown higher rates of fatalism among African American 
patients with cancer (Powe & Finnie, 2003). It was also predicted that patients with 
lower ejection fractions would be more likely to have behavioral intent to choose the ICD 
because of greater disease severity. No other specific predictions were made in terms 
of group differences.
CHAPTER II:  METHOD 
The current research was segmented into 2 parts including an initial design of the 
ICD-DAS via use of theory and research (part 1) and an assessment phase where the 
initial DAS was administered to potential ICD patients for scale development and 
validation (part 2).  
Part 1 
The first aim of the present study was to develop a scale consisting of important 
ICD pros and cons. This was accomplished by compiling the risks and benefits of the 
ICD by way of a review of the literature. The following is a description of the 
methodology of the initial development of the Implantable Cardioverter Defibrillator – 
Decision Analysis Scale (ICD-DAS). 
Procedure 
Examination of the ICD Literature. In constructing this questionnaire, a list of 
items that could influence potential ICD recipients in their choice for or against 
implantation was compiled. A generation of items began with a literature review by 
utilizing Pubmed searches. In addition, Google.com email alerts provided updates of the 
latest relevant Google results (web, news, journals, magazines, etc.) using the query of 
“implantable cardioverter defibrillator.” Benefits and consequences cited in the literature 
were listed in an excel spreadsheet. The literature review process provided a 
compilation of 121 items.  
Initial Item Reduction and Organization. Next, a rational grouping of variables 
allowed for reduction of total items to 24 (See Table 3).  Specifically, the 24 subsequent 
items broadly represented the 121 original items revising the collapsed items with a high 
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degree of redundancy by placing the items into groupings by similarity. To provide a 
framework for the risks and benefits revealed in this literature search, these 24 items 
were organized by use the Biopsychosocial-Spiritual Model. This holistic approach 
emphasizes various dimensions of a patient’s experience with illness and health. Table 
3 lists frequently noted pros and cons of the ICD organized by 1) rational groupings and 
2) use of the Biopsychosocial-Spiritual Model.  
 Expert Review of Items. Next, semi-structured qualitative interviews with 
providers were used to:  1) confirm the face validity of this refined list of relevant 
information pertaining to patient choice of the ICD and 2) to adjust the label of each of 
the 24 items to help best describe and represent the underlying items. Those 
interviewed included 2 cardiologists, 1 electrophysiologist, and 1 cardiac psychologist. 
These individuals were given a document with the individual cells in Table 3, as 
headings with a subset of the original 121 items below each heading. First, expert 
reviewers were asked if they believed that the 24 items were an accurate representation 
of the important pro and con domains of the ICD. Next, experts were asked circle any 
item they did not believe to belong in a certain group. Subsequently, they were asked to 
indicate if any item identified as being out of place could be placed in another of the 24 
groupings. Finally, experts were queried regarding their suggestions for alternate 
descriptions of the headings of each group. Adjustments were made to the wording to 
satisfy each reviewer. When there was contradictory feedback provided by the various 
reviewers, the principal investigator decided on wh
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Part 2 
The aim of the second phase of this study was to conduct an empirical test of the 
Biopsychosocial-Spiritual Model through patient assessment and factor analysis. 
Specifically, this was accomplished by recruitment of patients who rated items on the 
initial ICD-DAS and patient ratings were analyzed with factor analytic procedures. A 
sub-aim of this second phase was to analyze associations with the intent to choose an 
ICD and other psychosocial, demographic (i.e., gender, race, disease severity, and 
site), and socioeconomic variables (i.e., income, health insurance status, and 
educational background).  
Participants  
In the second phase of the study, 103 patients with a diagnosis of heart failure or 
coronary artery disease (CAD) receiving care at Pitt County Memorial Hospital, East 
Carolina University Physician Clinics, and associated satellite facilities in Greenville, 
NC. Stanford University Medical Center in Palo Alto, CA served as an additional site to 
allow for a more diverse sample. Those eligible for inclusion were individuals with 
ejection fractions (EFs) less than 50% and/or met criteria for an ICD. To participate in 
this study, patients were also required to be able to speak and read English, be at least 
age 18, and be deemed cognitively able to complete questionnaires by medical staff 
and research assistants. There were 89 patients who declined to participate because 
they were either ready to leave the clinic due to their long appointment times, did not 
have reading glasses, were deemed cognitively unable to complete the questionnaire, 
or declined with no reason given.  
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In the current sample, 67 participants were male and 36 participants were 
female. Patients ranged in age from 19 to 90 with a mean age of 54.86. The sample 
was 40.8% African American, 46.6 % Caucasian, 5.8% Hispanic, and 6.8% were 
classified as “Other.” The majority of patients was married (53.3%), followed by single 
(29.3%), widowed (10.9%), and divorced (6.5%). Stanford University participants 
comprised 36.9% of the total sample. East Carolina University (ECU) patients 
comprised 63.1% of the total sample. The majority of these patients had an ejection 
fraction of 50% or below; however, 5 participants with normal ejection fractions met 
medical criteria for implantation of the ICD and were recruited at Stanford. Also, 63.1% 
of the participants had EFs less than 35, 31.1% had EFs equal or greater than 35, and 
5.8% did not have their EF recorded by research assistants. 
This study received separate IRB approvals for East Carolina University (ECU) 
and Stanford University. A portion of the subjects at ECU were compensated $10.00 for 
their participation once funding was procured; however, some of the initial participants 
recruited at ECU and all of the Stanford participants were not compensated for their 
participation. More specifically, some participants were not compensated because grant 
funding was acquired after recruitment had begun. Table 4 shows the sample by 
recruitment site. The goal was to recruit as many potential ICD patients as possible that 
were in the actual process of making the ICD decision at the time of recruitment. 
Measures 
 Participants completed a short battery of psychosocial questionnaires. Patient 
decisional factors were assessed by the initial Implantable Cardioverter Defibrillator – 
Decision Analysis Scale (ICD-DAS). The scale consisted of 24-item, each of which was 
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placed on a 5-point rating scale designed to reveal the level of importance of pros and 
cons which most influence patient decision for or against the ICD. The scale also had 
an item placed on a 7-point rating scale ranging from “definitely no” to “definitely yes”:  
“If your doctor recommended an ICD, how likely would you be to get one?”  Since 
inclusion criteria were expanded beyond those who were indicated for the ICD, 
behavioral intent provided the closest approximation of actual choice available. 
General health-related quality of life was assessed with the Medical Outcomes 
Study-Short Form-12 Health Survey (SF-12), a 12-item revision of the SF-36 Health 
Survey (Ware et al., 1996) designed to reproduce the Physical Component Summary 
(PCS), and the Mental Component Summary (MCS) scores of the original measure. 
Compared to its predecessor the SF-36, each of the SF-12 summary scales accounted 
for over 90% of the variance in the SF-36 scales, demonstrated strong test-retest 
reliability (.89 for the PCS; .76 for the MCS) and correlated highly with the SF-36 
summary scales (Ware et al., 1996).  
The Hospital Anxiety & Depression Scale (HADS) (Zigmond et al., 1983) is a 14-
item measure that assesses depression and anxiety. HADS is a well-known, widely 
used instrument assessing levels of anxious (HADS-A) and depressive (HADS-D) 
symptomatology with Cronbach's alphas for HADS-A varying from .68 to .93 (mean .83) 
and for HADS-D from .67 to.90 (mean .82) in patient samples (Bjelland, Dahl, Haug, & 
Neckelmann, 2002).  
The Religious Health Fatalism Questionnaire (RHFQ) (Franklin et al., 2008) is a 
17-item measure of fatalistic beliefs. The RHFQ was created to understand fatalistic 
beliefs to a greater extent in African American religious communities and was 
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developed and tested within African American churches. Pilot and validity testing of the 
RHFQ (N = 292) showed that the measure had sufficient variability and construct 
validity and moderate internal consistency (alpha = .67). 
Form C of the Multidimensional Health Locus Of Control (C-MHLC) scale 
(Wallston et al., 1994) is an 18-item, general purpose, condition-specific locus of control 
scale that could easily be adapted for use with any medical or health-related condition. 
The standard MHLC is composed of 3 subscales: (1) internal health locus of control, 
which assesses the belief that one’s own behaviors affect one’s health status; (2) 
powerful others health locus of control, which assess the belief that powerful other 
people, such as doctors, nurses, family and friends have control over one’s health 
status; and (3) chance health locus of control, which assesses the belief that one’s 
health condition is a matter of fate, luck or chance. Each subscale is comprised of 6 
items, totaling 18 items on the questionnaire.  Internal consistency ranged from .70 to 
.87 in 2 separate samples (Wallston, Stein, & Smith, 1994). Form C has adequate 
concurrent validity as the measure has significant correlations with the appropriate 
subscales from versions A and B of the MHLC (Wallston, WalIston, & DeVellis, 1978).  
Form C breaks the powerful others subscale down into 2 separate subscales with 3 
items each and labeled “doctors” and “other people,” resulting in 4 total subscales for 
the measure. 
A standard demographic questionnaire was utilized to document age, gender, 
ethnic status, educational status, marital and employment status, and family income.  
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Procedure 
 The set of measures was administered to participants. Individuals were excluded 
from the study if they were (1) less than 18 years of age, (2) unable to read and write in 
English, or (3) were observed as cognitively impaired by recruiting healthcare providers. 
Potential participants, identified by their physician, were recruited following indication, 
referral, and the standard patient education for the ICD. Patients were checked into the 
clinic, where a research assistant approached them. Patients were asked about their 
interest in participating in a study that seeks to understand patient perceptions of the 
ICD. Research assistants explained the study and obtained informed consent. Following 
the informed consent process, patients were asked to complete the assessment battery.  
The battery consisted of a packet of questionnaires including the initial ICD-DAS, 
as well as a set of other psychosocial measures (i.e., HADS, SF-12, C-MHLC, and 
RHFQ). Medical record review and case report forms established demographic, 
socioeconomic, surgical, and medical factors related to response patterns on the 
decision analysis questionnaire. Patients also had the opportunity to list any pros or 
cons of getting the ICD that were not listed in the questionnaire. The conditional 
behavioral intent for ICD choice was assessed at the time of recruitment for all patients. 
Specifically, participants were asked to rate how likely they would be to choose the ICD 
(on a 7-item rating scale), if the device were to be recommended by their physician. 
Patients were thanked for their participation. Some of the patients received 
compensation for their participation, which was implemented when funding was 
received for the project. The patients then completed their medical visit.  The final 
procedure of the project was the psychometric evaluation of the initial ICD-DAS. 
44
 
Proposed Analyses 
Part 1 
A thorough review of the ICD literature was proposed as the method for 
identifying pros and cons of the ICD that would be relevant for subsequent analysis.  
Items were to be placed in rational groupings based on similarity. Finally, qualitative 
analyses were planned to be conducted by expert reviews by cardiac experts in order to 
confirm themes from the rational groupings. Any discrepancy between experts’ reviews 
was to be adjudicated by the principal investigator. The final themes that emerge form 
this process were to be used as items in the initial design of the ICD-DAS.  
Part 2 
 The current study proposed to subject participant ratings of items on the initial 
ICD-D to factor analysis, and it was expected that a four-factor solution (representing 
each of the 4 tenets of the Biopsychosocial-Spiritual Model) would result. This statistical 
procedure was used because of its ability to take a single set of variables and then form 
coherent subsets (Tabachnick & Fidell, 2007). Use of Cronbach’s Alpha was planned as 
a measure of internal consistency of the total scale and any sub-scales. Multiple 
regression analyses were planned to assess the degree to which 1) the ICD-DAS (or 
any subscales) and 2) a set of psychosocial measures (representing tenets of the 
Biopsychosocial-Spiritual Model) could predict behavioral intent to choose the ICD. It 
was predicted that the ICD-DAS would be superior to the set of psychosocial measures 
in predicting ICD behavioral intent. Finally, several t-tests were planned to determine 
differences between demographic groups on the ICD-DAS, psychosocial measures, and 
socioeconomic variables. 
CHAPTER III: RESULTS 
Part 1 
Each of the 24 items identified (See Table 3) were placed on a rating scale with 5 
choices. Participants could choose one of the following for each item: “Not Important at 
all”; “Slightly Important”; “Moderately Important”; “Very Important”; “Extremely 
Important.” The scale asked participants to rate the level of importance for each 
statement in terms of making their decision for or against the ICD. These 24 items, with 
an additional item assessing the behavioral intent of patients to choose the ICD: “If your 
doctor recommended an ICD, how likely would you be to get one?” Conditional 
behavioral intent was assessed because there was no method available to assess the 
patient’s final decision until they actually accepted or refused the device. Since we were 
unsure of the number of patients who would make a final decision at the time of 
recruitment, this allowed us to assess the closest construct to actual ICD choice.  
The 24 rating scale questions and the item that asked the likelihood of choosing 
an ICD comprised the original Implantable Cardioverter Decision Analysis Scale (ICD-
DAS). The initial ICD-DAS is shown in Appendix B. Note that the “Agree/Disagree” and 
qualitative portions of the initial ICD-DAS were not examined in the current study. 
Table 3 
Highlighted Pros and Cons of the ICD 
 
  
Biological/ 
Medical 
 
 
Psychological 
 
Social 
 
Spiritual/ 
 Existential 
 
Pros Extends life (e.g., 
Koller et al., 
2008).  
DAS item 1 
Perceived safety 
(e.g., Lemon & 
Edelman, 2007). 
DAS item 24 
Ability to engage 
in social 
activities (e.g., 
Lemon & 
Getting another 
chance at life (e.g., 
Agard, Lofmark, 
Edvardsson, & 
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Edelman, 2007). 
DAS item 21 
Ekman, 2007). 
DAS item 4 
 Prevents death 
(e.g., Bardy et al., 
2005). 
DAS item 3 
Confidence to be 
active (e.g., 
Zimetbaum & 
Discussant, 
2007). 
DAS item 6 
Spousal comfort 
(e.g., Sowell et 
al., 2007). 
DAS item 13 
Faith that the 
appropriate referral 
has been made (e.g., 
Agard, Lofmark, 
Edvardsson, & 
Ekman, 2007). 
DAS item 8 
 Well-studied 
treatment option 
(e.g., Epstein, 
2008). 
DAS item 9 
Equal or better 
quality of life, 
anxiety, and/ or 
depression after 
implant (e.g., 
Francis, 
Johnson, & 
Niehaus, 2006). 
DAS item 10 
Desire to 
continue 
relationships as 
long as possible 
(e.g., Burns, 
Serber, Keim, & 
Sears, 2005). 
DAS item 11 
Faith that the ICD is 
the best option (e.g., 
Agard, Lofmark, 
Edvardsson, & 
Ekman, 2007). 
DAS item 12 
Cons Shock (e.g., 
Daubert et al., 
2008). 
DAS item 2 
Depression (e.g., 
Whang, Albert, & 
Sears, 2005).  
DAS item 14 
 
Spousal/familial 
distress (e.g., 
Anderson, 
2007).  
DAS item 15 
 
Preference for 
natural death (e.g., 
Zimetbaum & 
Discussant, 2007). 
DAS item 16 
 Recall/ device 
replacement/ 
battery 
replacement (e.g., 
Gibson, Kuntz, 
Levenson, & 
Ellenbogen, 
2008). 
DAS item 17 
Anxiety (e.g., 
Sowell, Sears, 
Walker, Kuhl, & 
Conti, 2007). 
DAS item 18 
Fear of shock/ 
embarrassment 
(e.g., Steinke et 
al., 2005). 
DAS item 19 
Low faith that the 
appropriate referral 
has been made (e.g., 
Zimetbaum & 
Discussant, 2007).  
DAS item 20 
 
 
 Surgical risk/ 
infection (e.g., 
Klug et al., 2007). 
DAS item 5 
Lower quality of 
life (Passman et 
al., 2007). 
DAS item 22 
Body image 
concerns (e.g., 
Sowell, Kuhl, 
Sears, Klodell, & 
Conti, 2006) 
DAS item 23 
Against religious or 
spiritual beliefs (e.g. 
Franklin, Schlundt, & 
Wallston, 2008). 
DAS item 7 
 
 Part 2 
A total of 192 patients were approached to participate in the study, and 103 
agreed to participate. Table 4 below shows the recruitment totals and recruitment by 
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site. A thorough discussion of the sample’s general characteristics can been seen on 
pages 42-43. While many of the patients at Stanford and some patients at ECU were 
near their decision point to make a final choice of getting or not getting an ICD, all 
patients were assessed based on their conditional behavioral intent. Some patients 
were not asked by their physicians to make a final choice regarding the ICD, and for a 
subset of patients, actual patient decision was not applicable because they did not meet 
full-criteria for the ICD. Data regarding actual choice is not presented in this manuscript. 
Further analysis of actual receipt of the device may be the focus of a subsequent 
analysis of a future manuscript. 
Table 4 
Recruitment Totals and Recruitment by Site 
                               Recruitment Site 
  
East Carolina  Stanford   
 
Total 
 
  N  N  N 
Sample  65  38  103 
Male  42  25  67 
Female  23  13  36 
EF < 35  41  24  65 
EF ≥ 35  23  9  32 
White  22  25  47 
Black  41  2  43 
Other  2  11  13 
 
Sample Psychosocial Characteristics  
Means and standard deviations for the sample’s psychosocial characteristics are 
shown in Table 5. The current sample’s depression and anxiety scores were assessed 
with the Hospital Anxiety and Depression Survey (HADS). A score of 0 to 7 for either 
HADS subscale is regarded as being in the normal range, a score of 8 to 10 suggesting 
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of the presence of the respective state, and a score of 11 or higher indicating probable 
presence of a diagnostic anxiety or depressive disorder (Snaith, 2003). The current 
sample had 53.92% of participants with anxiety in the normal range, with 17.64% of 
participants with anxiety in the medium range and 28.43% in the higher range of anxiety 
symptoms. The current sample had 70.59% of participants with depression in the 
normal range, with 9.80% of participants with depression in the medium range and 
19.61% in the higher range of depressive symptoms. Most participants had normal 
levels of anxiety and depression; however, a substantial number of participants 
endorsed significant levels of affective distress. 
The SF-12 was used to assess physical and mental quality of life in the current 
sample. The SF-12 uses standardized scores (M = 50, SD=10) for normative 
comparisons. The sample was more than 1 standard deviation below normative 
standards on the physical quality of life. The sample was within normative standards on 
the mental quality of life. The current sample would be expected to have lower physical 
quality of life given the physical limitations associated with heart failure. Overall, the 
current sample appears to have fairly normal mental quality of life with suggests 
psychological and emotional adjustment to physical limitations. 
The Religious Health Fatalism Questionnaire (RHFQ) was used to assess 
religious health fatalism in the current sample. Higher levels of fatalism are associated 
with relatively higher scores. The current sample had a mean score of 51, which is also 
the median score on this measure. This indicates that, as a whole, the sample was 
relatively balanced in terms of religious health fatalism. 
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The Multidimensional Health Locus of Control - Form C (C-MHLC) was used to 
assess locus of control in the current sample. Overall, the sample expressed relatively 
higher levels of internal locus of control (M = 24.15) than chance locus of control (M = 
16.38). The sample was comparable to the means and standard deviations to the 
normative groups used to validate the C-MHLC (Wallsten, Stein, & Smith, 1994).  
Means and standard deviations for the current sample on C-MHLC are shown in Table 
5 below. These results are consistent with other chronic disease samples (i.e., 
rheumatoid arthritis, cancer, chronic pain, and diabetes) that were analyzed in the 
construction of the C-MHLC (Wallsten et al., 1994). 
Table 5 
 
Sample Means and Standard Deviations on Psychosocial Measures 
Measure  Possible Range M SD N 
HADS Anxiety  0-21 7.78 5.15 102 
HADS Depression  0-21 5.98 4.98 102 
SF-12 Physical Component 
Score 
 0-100 37.56 10.89 98 
SF-12 Mental Component 
Score 
 0-100 48.78 10.91 98 
Religious Health Fatalism  17-85 51 18.76 98 
C-MHLC Internal  6-36 24.15 6.60 98 
C-MHLC Chance  6-36 16.38 6.96 97 
C-MHLC Doctors  3-18 15.58 2.67 101 
C-MHLC Others  3-18 11.35 3.75 100 
 
Factor Analysis 
An exploratory principal factors analysis procedure with direct oblimin rotation 
was performed using PASW 18 software (formerly SPSS). PASW Factor was utilized to 
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examine 24 items in a sample of 103 prospective ICD recipients.  Principal components 
extraction was used prior to principal factors extraction to estimate the number of 
factors, the presence of multicollinearity, and the factorability of the correlation matrices. 
An exploratory principal factors analysis procedure was then chosen to analyze the 
current data because of its ability to take a single set of variables and then form 
coherent and reasonably independent subsets (Tabachnick & Fidell, 2007). Therefore, 
we examined and interpreted the factors solutions to determine the number and nature 
of factors. 
Prior to running the analysis, the first step was to assess the suitability of the 
data for factor analysis. Sample size is an important consideration, and the general 
consensus appears to be that the larger the sample, the more accurate and 
generalizable the results of the factors. Also, the sample size must exceed the number 
of variables being analyzed. The current study had 103 participants and 24 variables. 
While some statisticians estimate that the sample should be at least 10 times the 
number of variables for the correlation coefficients to be reliable (Tabachnick & Fidell, 
2007), others conclude that a sample size is sufficient if the variables have several high 
loading marker variables above .80 (Stevens, 1996).  
The current sample has more participants than variables, several high loading 
marker variables, and is a relatively large sample considering the practical limitations of 
recruiting potential cardiac device patients who met criteria for the study. When 
communalities are high, this has been found to reduce the effect of relatively lower 
sample size (MacCallum, Widaman, Zhang, & Hong, 1999).   
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To determine normality in the sample prior to factor analysis, SPSS Frequencies 
was used to display skewness of each of the items under consideration. Many of the 
variables were negatively skewed, some were normally distributed, and others were 
positively skewed. As such, significance testing was therefore not performed.  It is an 
acknowledgeable limitation of the current study that the lack of normality of many of the 
items may have slightly weakened the analysis due to lower correlations with R. This 
could result in some cases having undue influence on the solution. Skewness was not 
dramatic on any of the items and nonlinear monotonic transformations to reduce the 
skewness were not considered necessary. 
As previously described, principal components extraction was initially used to 
estimate the number of factors, the absence of multicollinearity, and the factorability of 
the correlation matrices.  Six factors with eigenvalues ≥1 (1 being the minimum level for 
a factor to be considered strong enough for further analysis and interpretation) were 
extracted in 17 iterations, accounting for 70.75% of the variability in the scores (see 
Table 6 below).  
Table 6  
Initial Principal Components Analysis 
Total Variance Explained 
Component 
 
Initial Eigenvalues 
Total % of Variance Cumulative % 
 
1 9.170 38.209 38.209 
2 3.115 12.979 51.188 
3 1.248 5.201 56.389 
4 1.214 5.057 61.446 
5 1.154 4.808 66.254 
6 1.079 4.496 70.750 
7 .926 3.858 74.608 
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8 .793 3.304 77.912 
9 .704 2.932 80.844 
10 .604 2.517 83.361 
11 .551 2.296 85.657 
12 .475 1.978 87.635 
13 .467 1.944 89.579 
14 .390 1.623 91.202 
15 .350 1.457 92.660 
16 .335 1.397 94.057 
17 .293 1.220 95.276 
18 .257 1.070 96.346 
19 .208 .867 97.212 
20 .177 .737 97.949 
21 .167 .696 98.645 
22 .123 .514 99.159 
23 .102 .425 99.585 
24 .100 .415 100.000 
*Extraction Method: Principal Component Analysis. 
 
Multicollinearity and singularity can be a problem with factor analysis. Regarding 
multicollinearity, if tolerance is too low for any of the variables, the tolerance may be 
adjusted to prevent the items from being removed from the subsequent analysis. If 
singularity exists, one or more of the variables may be deleted since there may be at 
least 2 items measuring the same dimension.  Problems with multicollinearity or 
singularity did not exist in the current data. More specifically, the PASW FACTOR 
correlation matrix (not shown due to the excessive size of the table) presented several 
correlations greater than .30, and therefore patterns in the item responses were 
anticipated.  Also, the anti-image correlation matrix was also reviewed and there were 
several low correlations between variables, and high correlations along the axis (not 
shown due to the excessive size of the table).  
The principal components extraction was also used to assess the strength of the 
inter-correlations among the items. Kaiser’s (1974) measure of sampling adequacy 
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(MSA) was employed. Small values of MSA indicate that the correlation between 
variables is unique or not related to the remaining variables outside each simple 
correlation. Kaiser has described MSAs above .5 as acceptable, although .8 or better is 
ideal. The KMA of the current sample was .824 with principal components extraction. 
The partial correlations found in the Anti-Image Correlation Matrix (not shown due to the 
excessive size of the table) revealed large MSAs with the majority above .80.  
As shown previously, the principal components extraction revealed 6 factors with 
an eigenvalue greater than 1 (see Table 6). Next, a scree plot was used to graphically 
represent the factor solution and the percentage of variance explained by the solution 
(see Figure 2).  Only 2 of the 6 factors with eigenvalues above 1 were above the elbow 
in the scree plot, indicating the likelihood that only 2 factors should be retained for 
further analysis.  
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Figure 2 
Scree Plot 
 
An exploratory principal axis factor analysis was then used to analyze the 
variables, forcing the extraction of only 2 factors based on the information gathered 
previously. Items with loadings of 0.45 or higher on one of the factors that did not have 
a loading of 0.30 or higher on any other factor were considered to be “good” measures 
of the factor on which they loaded (Grimm & Yarnold, 1997). A varimax rotation was 
initially utilized but produced 4 of 24 items loaded highly with both factors, failing to 
meet the loading criteria just described. Rather than remove all 4 items, a direct oblimin 
rotation was then employed to improve the interpretability of factor loadings. The 
principal axis factor analysis with direct oblimin rotation produced 2 factors that had 2 
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items (i.e., surgical risk and social activity) that loaded with relative strength on each 
factor (see Table 7).  
Table 7  
Factor Analysis with 24 items and 2 Factors 
Pattern Matrix 
 
Factor 
1 2 
Anxiety (18) .870   
Low QOL (22) .776   
Shock humility (19) .772   
Body image (23) .741   
Unhappy (14) .727   
Family worry (15) .687   
Against beliefs (7) .678   
Natural death (16) .661   
Device repair (17) .657   
Doctor diffidence (20) .605   
Shocks (2) .597   
Surgical risk (5) .423 .312 
Social activity (21) .391 .388 
Faith (12)   .760 
Efficacy (9)   .721 
Safety (24)   .706 
Family comforted (13)   .698 
Longer life (1)   .682 
QOL (10)   .628 
Relationships (11)   .591 
Activity confidence (6)   .574 
Doctor confidence (8)   .515 
Another chance (4)   .493 
Prevents death (3)   .485 
Extraction Method: Principal Axis Factoring.  
Rotation Method: Oblimin with Kaiser Normalization. 
Rotation converged in 6 iterations. 
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These 2 items were removed from the subsequent analysis because they failed to load 
well on either of the factors.  
The principal axis factor analysis with direct oblimin rotation was again used to 
analyze the 22 remaining items related to ICD Intent. This final use of the SPSS 
FACTOR procedure revealed 2 factors, each with 11 distinct items (see Table 8).  
Table 8  
Factor Analysis with 2 Items Removed 
Pattern Matrix 
 
Factor 
1 2 
Anxiety (18) .868   
Low QOL (22) .767   
Shock humility (19) .764   
Body image (23) .735   
Unhappy (14) .723   
Against beliefs (7) .678   
Family worry (15) .676   
Natural death (16) .662   
Device repair (17) .649   
Doctor diffidence (20) .606   
Shocks (2) .592   
Faith (12)   .764 
Efficacy (9)   .724 
Longer life (1)   .687 
Safety (24)   .682 
Family comforted (13)   .677 
QOL (10)   .638 
Relationships (11)   .599 
Activity confidence (6)   .571 
Doctor confidence (8)   .524 
Prevents death (3)   .487 
Another chance (4)   .483 
Extraction Method: Principal Axis Factoring.  
Rotation Method: Oblimin with Kaiser Normalization. 
Rotation converged in 5 iterations. 
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The eigenvalues for the 2 factors were extracted in 5 iterations. The 2 factors 
accounted for 47.35% of the variance in scores. These 22 items were retained for 
further evaluation. The first factor consisted of 11 negative consequences of receiving 
the ICD. The second factor included 11 advantages of receiving the ICD. These 2 
factors formed in a structure that was congruent with hypothesized pros and cons of the 
ICD and were therefore accepted as appropriate to proceed with assessing reliability 
estimates of the factors.  The factors were named “ICD Pros” and “ICD Cons” 
accordingly. 
Reliability Estimates 
Reliability of the unit-weighted subscales was assessed in terms of internal 
consistency. Cronbach’s Alpha assessed all possible split-halves to determine if items 
intended to measure the same general construct produced similar scores. A Cronbach’s 
alpha of 0.91 was obtained for the ICD Cons factor. Alpha could not have been 
improved by removal of any of the items (See Table 9). 
Table 9  
Cronbach's Alpha if “ICD Con” Item Deleted 
Item-Total Statistics 
 
Scale 
Mean if 
Item 
Deleted 
Scale 
Variance if 
Item 
Deleted 
Corrected 
Item-Total 
Correlation 
Cronbach's 
Alpha if Item 
Deleted 
Anxiety (18) 31.14 101.527 .781 .895 
Low QOL (22) 31.29 102.139 .748 .896 
Shock humility (19) 31.69 100.905 .696 .899 
Body image (23) 31.69 100.096 .728 .897 
Unhappy (14) 31.40 104.838 .660 .901 
Against beliefs (7) 32.05 102.974 .602 .905 
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Family worry (15) 31.08 106.481 .617 .903 
Natural death (16) 30.74 106.646 .597 .904 
Device repair (17) 30.53 110.181 .647 .903 
Doctor diffidence (20) 30.92 105.291 .631 .902 
Shocks (2) 31.22 109.295 .547 .906 
 
A Cronbach’s alpha of 0.88 was obtained for the ICD Pros factor.  Alpha could 
not have been improved by removal of any of the items.  Both ICD Pros and ICD Cons 
had strong reliability estimates (See Table 10).  
Table 10 
Cronbach's Alpha if an “ICD Pro” Item Deleted 
Item-Total Statistics 
 
Scale 
Mean if 
Item 
Deleted 
Scale 
Variance if 
Item 
Deleted 
Corrected 
Item-Total 
Correlation 
Cronbach's 
Alpha if Item 
Deleted 
Efficacy (9) 40.86 47.174 .686 .865 
Faith (12) 41.01 45.305 .697 .863 
Longer life (1) 40.53 49.033 .660 .869 
Safety (24) 41.07 44.531 .604 .870 
Family comforted (13) 41.02 45.780 .575 .872 
Activity confidence (6) 41.08 45.517 .631 .867 
Doctor confidence (8) 40.89 47.342 .540 .873 
QOL (10) 40.82 47.662 .640 .868 
Relationships (11) 40.88 47.034 .625 .868 
Prevents death (3) 40.71 49.330 .419 .881 
Another chance (4) 40.88 46.693 .540 .874 
 
A Cronbach’s alpha of 0.92 was obtained for the entire measure that included all 
22 retained items.  Alpha could not have been improved by removal of any of the items.  
The total scale as well as both ICD Pros and ICD Cons had strong reliability estimates 
(See Table 11). The final ICD-DAS is shown in Figure 3 below. 
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Table 11 
Cronbach's Alpha if an ICD-DAS Item Deleted 
Item-Total Statistics 
 
Scale 
Mean if 
Item 
Deleted 
Scale 
Variance if 
Item 
Deleted 
Corrected 
Item-Total 
Correlation 
Cronbach's 
Alpha if Item 
Deleted 
Longer life (1) 75.06 255.599 .473 .915 
Shocks (2) 76.30 245.778 .492 .915 
Prevents death (3) 75.25 257.499 .263 .918 
Another chance (4) 75.43 247.582 .514 .914 
Activity confidence (6) 75.62 244.290 .619 .912 
Against beliefs (7) 77.16 235.729 .571 .913 
Doctor confidence (8) 75.42 249.323 .497 .914 
Efficacy (9) 75.41 251.757 .522 .914 
QOL (10) 75.35 250.334 .570 .914 
Relationships (11) 75.43 249.941 .531 .914 
Faith (12) 75.52 247.868 .563 .913 
Family comforted (13) 75.57 251.582 .377 .917 
Unhappy (14) 76.47 237.483 .647 .911 
Family worry (15) 76.15 238.284 .658 .911 
Natural death (16) 75.87 240.522 .557 .913 
Device repair (17) 75.58 246.144 .626 .912 
Anxiety (18) 76.18 236.045 .691 .910 
Shock humility (19) 76.75 235.730 .586 .913 
Doctor diffidence (20) 76.03 236.204 .641 .911 
Low QOL (22) 76.41 233.911 .714 .910 
Body image (23) 76.80 230.548 .700 .910 
Safety (24) 75.61 247.985 .435 .916 
 
The final ICD-DAS is shown in Figure 3 below. The 2 removed items that were 
removed after completion of the factor analysis are in bold font.  
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Figure 3 
The Final Implantable Cardioverter Defibrillator – Decision Analysis Scale  
 
The ICD is designed to provide a shock to prevent sudden cardiac arrest. Special medications may 
reduce the number of serious heart rhythm problems, but do not reduce the risk of sudden cardiac arrest. 
Some patients decide that receiving the ICD is their best option. Other patients decide to decline the ICD 
and do not receive therapy to prevent sudden cardiac arrest. Below are some statements that describe 
what some people find important in their decision regarding whether or not to get the ICD, Please rate 
how important the following statements are to you by checking the most appropriate box. 
 
  Not 
Important  
at all 
Slightly 
Important 
Moderately 
Important 
Very 
Important 
Extremely 
Important 
1 The ICD increases my 
chances of a longer life + 1 2 3 4 5 
2 The ICD may give me a 
strong shock - 1 2 3 4 5 
3 The ICD prevents death + 1 2 3 4 5 
4 The ICD gives me another 
chance at life + 1 2 3 4 5 
5 There is a surgical 
risk and chance of 
infection if I get the 
ICD - 
1 2 3 4 5 
6 The ICD gives me 
confidence to be physically 
active + 
1 2 3 4 5 
7 It is against my beliefs to 
get the ICD -  1 2 3 4 5 
8 The doctor seems confident 
that I should get the ICD + 1 2 3 4 5 
9 The ICD is a well-studied 
treatment option + 1 2 3 4 5 
10 Most people who get an 
ICD have a good quality of 
life and mental health + 
1 2 3 4 5 
11 The protection of the ICD 
allows me to continue 
relationships as long as 
possible + 
1 2 3 4 5 
12 I have faith that the ICD is 
my best option+ 1 2 3 4 5 
13 My spouse and/or family 
will be comforted if I get the 
ICD + 
1 2 3 4 5 
14 Some people with ICDs 
become depressed after 
getting the device - 
1 2 3 4 5 
15 My spouse/ family 
members may be worried if 
I am shocked by the ICD - 
1 2 3 4 5 
16 I prefer to have natural 
death without being 1 2 3 4 5 
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shocked by the ICD - 
17 At some point, parts or all 
of the ICD may need to be 
replaced -  
1 2 3 4 5 
18 Some people with ICDs 
become anxious after 
getting the device - 
1 2 3 4 5 
19 I fear the embarrassment of 
getting shocked around 
other people - 
1 2 3 4 5 
20 The doctor does not seem 
confident that I should get 
the ICD - 
1 2 3 4 5 
21 The ICD will 
provide the ability to 
engage in activities 
with other people + 
1 2 3 4 5 
22 Some people with ICDs 
have a lower quality of life 
after getting the device - 
1 2 3 4 5 
23 I do not want other people 
to see my scar or ask me 
questions about my 
condition - 
1 2 3 4 5 
24 I will feel safer with an ICD 
+ 
1 2 3 4 5 
Note: Pro and con items are respectively denoted with (+) or (-). The 2 items removed 
from the measure are denoted with bold font. 
 
Defining ICD-DAS Subscales 
The ultimate aim of this project was to identify the factors, or subscales, so that 
they could be utilized in clinical and/or research activities. Therefore, a regression 
analysis was utilized to define subscales on the ICD-DAS, with a subscale representing 
each of the 2 factors. Each participant’s factor score was obtained by multiplying their 
standardized scores on the variables by the standardized scoring coefficients. PASW 
was used to output the factor scores of each participant into the data set for use in 
subsequent procedures.  Next, multiple regression analysis was then utilized to predict 
ICD Intent from factor scores on the ICD Pros and ICD Cons. Basic descriptive statistics 
and regression coefficients are shown in Table 12.  The only predictor variable that had 
a significant (p < .01) zero-order correlation with ICD Behavioral Intent was ICD Pros, 
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but both the ICD Pros and ICD Cons had significant (p < .01) partial effects in the full 
model.  The two predictor model was able to account for 34% of the variance in ICD 
Intent, F(2,74) = 18.97, p < .001, r2 = .34.   
Table 12 
 
ICD Intent Related to ICD Pros and ICD Cons (N = 30). 
 Zero-Order r β sr b 
Variable ICD Cons ICD Pros ICD Intent    
ICD Pros       .429* .626* .560 1.092 
ICD Cons         .447*    -.161 -.440* -.394 -.763 
    Intercept =  5.57 
Mean -0.003 -0.009    5.56    
SD 0.95 0.95    1.65 R2 =  .34*  
  *p < .01 
 
The means and standard deviations for the final measure based on actual scores 
are shown in Table 13 in below. 
Table 13 
Mean and Standard Deviations on the ICD-DAS Subscales and Total Measure 
 
Measure Possible Range M SD N 
ICD-DAS Total 22-110 79.49 16.34 79 
ICD Cons 11-55 34.38 11.20 85 
ICD Pros 11-55 45.18  7.49 83 
 
Using Psychosocial Measures to Predict ICD Intent 
 
With the 2-factor ICD-DAS solution appearing to be useful in predicting ICD 
Intent, there was interest in determining if a standard set of psychosocial measures (i.e., 
HADS, C-MHLC, SF-12, and RHFQ) could also predict ICD Intent.  
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A sequential multiple regression analysis was utilized to predict ICD Intent.  On 
the first step, HADS-A, HADS-D, C-MHLC Internal, C-MHLC Chance, C-MHLC Doctors, 
C-MHLC Others, SF-12 Physical, SF-12 Mental, and RHFQ were entered into the 
model.  This set of predictors was not significantly correlated with ICD Intent, F(9, 70) = 
1.142, p = .348, R2 = .14, 95% CI [.325, 8.237].  On the second step, ICD Pros and ICD 
Cons were entered simultaneously, resulting in a significant increase in R2, F(2, 59) = 
19.36, p < .001.  The full model R2 was significantly greater than zero, F(11, 70) = 
5.017, p < .001, R2 = .48, 95% CI [.738, 7.292]. Other than ICD Pros and ICD Cons, 
none of the predictor variables had a significant zero-order correlation with ICD Intent. 
These results suggest that the ICD-DAS (ICD Pros and ICD Cons) may be more useful 
in attempting to understand patient choice than a set of general measures. More 
specifically, the ICD-DAS may provide additional or more efficient clinical utility than 
already established measures. Discriminative validity was demonstrated as the ICD-
DAS scales was better at predicting ICD-Intent, than the set of psychosocial measures. 
Comparisons by Recruitment Site 
To determine if there were any significant differences on a number of 
socioeconomic variables between East Carolina and Stanford participants, independent 
samples t-tests were utilized. Means, standard deviations, sample sizes appear in Table 
14 below. Scores with significant differences were given confidence intervals and 
effects sizes. Stanford participants had a significantly higher educational background 
than East Carolina participants, t(60.51) = 2.437, p = .018, d = .62, 95% CI [.1065, 
1.1228]. Stanford participants also had significantly higher yearly income (in thousands) 
than ECU participants t(27.28) = 4.608, p < .001, d = 1.17, 95% CI [.5748, 1.7430]. In 
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addition, Stanford participants were significantly more likely to have health insurance 
than ECU participants, t(77.11) = 3.852, p < .001, d = .80, 95% CI [.3734, 1.2297].  
Independent samples t-tests were then conducted to test differences between 
Stanford and East Carolina patients on several psychosocial variables, including ICD 
Pros and ICD Cons. Means, standard deviations, sample sizes appear in Table 14 
below. Scores with significant differences were given confidence intervals and effects 
sizes. Stanford participants had significantly higher physical quality of life scores than 
East Carolina participants t(96) = 3.980, p < .001, d = .83, 95% CI [.4025, 1.2522]. East 
Carolina participants had significantly higher depression scores than Stanford 
participants t(97.61) = 5.260, p < .001, d = 1.08, 95% CI [.6459, 1.5036]. East Carolina 
participants had significantly higher anxiety scores than Stanford participants t(99.25) = 
3.647, p < .001, d = .75, 95% CI [.3305, 1.1597]. East Carolina participants had 
significantly higher scores on religious health fatalism than Stanford participants t(96) = 
4.312, p < .001, d = .89, 95% CI [.4662, 1.3174]. East Carolina participants had 
significantly higher scores on ICD Cons than Stanford participants t(77) = 2.858, p = 
.005, d = .68, 95% CI [.2008, 1.1637]. Finally, Stanford participants reported significantly 
higher behavioral intent to choose the ICD than East Carolina participants t(90.94) = 
2.442, p = .017, d = .50, 95% CI [.0913, .9121]. 
Table 14 
Site Comparisons 
 Site 
Measure East Carolina  Stanford 
 M SD N  M SD N 
Yearly Income* 29.29 21.84 39  106.64 83.73 26 
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(Thousands) 
Insurance Coverage* 0.72 0.45 58  0.97 0.16 38 
Years of Education** 12.50 2.65 57  14.24 3.75 37 
ICD Intent** 5.44 1.63 62  5.83 1.46 38 
HADS Anxiety* 9.02 5.56 64  5.71 3.59 38 
HADS Depression* 7.55 5.37 64  3.34 2.67 38 
SF-12 Physical 
Component Score 34.38 10.40 
61  42.79 9.70 37 
SF-12 Mental 
Component Score 47.24 11.31 
61  51.32 9.85 37 
Religious Health 
Fatalism 
Questionnaire* 
56.98 16.47 60  41.55 18.44 38 
C-MHLC Internal 24.53 6.83 62  23.50 6.23 36 
C-MHLC Chance 15.95 7.49 60  17.08 6.04 37 
C-MHLC Doctors 15.51 2.88 63  15.72 2.34 38 
C-MHLC Others 11.16 4.16 62  11.66 3.01 38 
ICD Cons** 0.21 0.84 53  -0.42 1.08 26 
ICD Pros -0.09 0.97 35  0.19 0.88 26 
* = p < .001. 
** = p < .05. 
 
Comparisons by Race 
To determine if there were any significant differences on a number of 
socioeconomic variables between Caucasian and African American participants, 
independent samples t-tests were utilized. Means, standard deviations, sample sizes 
appear in Table 15. Scores with significant differences were given confidence intervals 
and effects sizes. Caucasian participants had a significantly higher educational 
background than African American participants, t(76.08) = 2.838, p = .006, d = .64, 95% 
CI [.1849, 1.0934]. Caucasian participants also had significantly higher yearly income 
than African American participants, t(44.34) = 3.309, p = .002, d = .89, 95% CI [.3262, 
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1.4404]. In addition, Caucasian participants were significantly more likely to have health 
insurance than African American participants, t(44.47) = 4.148, p < .001, d = .91, 95% 
CI [.4374, 1.3786]. 
Independent samples t-tests were then conducted to test differences between 
African American and Caucasian patients on several psychosocial variables, including 
ICD Pros and ICD Cons. Means, standard deviations, sample sizes appear in Table 15. 
Scores with significant differences were given confidence intervals and effects sizes. 
African American patients in the sample reported higher levels of depressive symptoms, 
t(87) = 1.984, p = .050, d = .42, 95% CI [-.0007, .8409], religious health fatalism, t(83) = 
5.138, p < .001, d = 1.12, 95% CI [.6579, 1.5782], and ICD Cons, t(70) = 3.688, p < 
.001, d = .87, 95% CI [.3826, 1.3508] than Caucasian participants.  
Table 15 
Racial Comparisons  
 Race 
Measure African American  Caucasian 
 M SD N  M SD N 
Yearly Income** 
(Thousands) 30.45 31.43 24  81.06 79.73 33 
Insurance Coverage* 0.64 0.49 39  0.98 0.15 44 
Years of Education** 12.22 2.61 36  14.17 3.50 43 
ICD Intent 5.35 1.70 40  5.83 1.46 47 
HADS Anxiety 8.71 6.18 42  7.28 4.25 47 
HADS Depression** 7.48 5.52 42  5.34 4.63 47 
SF-12 Physical 
Component Score 37.49 10.35 
39  36.51 11.53 46 
SF-12 Mental 
Component Score 48.94 11.15 
39  47.98 10.49 46 
Religious Health 61.63 15.52 38  43.83 16.17 47 
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Fatalism 
Questionnaire* 
C-MHLC Internal 25.00 6.94 41  22.82 6.28 45 
C-MHLC Chance 16.20 8.22 40  16.62 6.25 45 
C-MHLC Doctors 15.07 3.17 42  15.72 2.34 46 
C-MHLC Others 11.12 4.52 41  11.26 2.82 46 
ICD Cons* 0.42 0.89 35  -0.33 .84 37 
ICD Pros -0.11 1.12 35  0.07 0.75 37 
* = p < .001. 
** = p ≤ .05. 
 
Comparisons by Gender 
Independent samples t-tests were also conducted to test differences between 
male and female patients on several outcome variables, including ICD Pros and ICD 
Cons. Means, standard deviations, sample sizes appear in Table 16. Scores with 
significant differences were given confidence intervals and effects sizes. Male patients 
in the sample reported higher levels of internal health locus of control, t(96) = 4.359, p < 
.001, d = .92, 95% CI [.4837, 1.3499] and lower levels of ICD Pros, t(77) = 2.161, p = 
0.34, d = .50, 95% CI [.0387, .9672] than female participants.  
Table 16 
Gender Comparisons  
 Gender 
Measure Male  Female 
 M SD N  M SD N 
Yearly Income 
(Thousands) 60.55 69.52 42  59.65 63.46 23 
Insurance Coverage 0.78 0.42 64  0.91 0.30 32 
Years of Education 13.11 3.43 60  13.43 2.87 30 
ICD Intent 5.68 1.51 65  5.77 1.63 35 
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HADS Anxiety 7.15 4.97 66  8.94 5.35 36 
HADS Depression 5.56 4.53 66  6.75 5.70 36 
SF-12 Physical 
Component Score 38.04 11.02 
64  36.64 10.76 34 
SF-12 Mental 
Component Score 48.95 10.18 
64  48.46 12.34 34 
Religious Health 
Fatalism 
Questionnaire 
50.79 18.90 66  51.44 18.76 32 
C-MHLC Internal* 26.14 5.95 63  20.57 6.27 35 
C-MHLC Chance 17.26 7.06 62  14.83 6.60 35 
C-MHLC Doctors 15.72 2.55 65  15.33 2.91 36 
C-MHLC Others 11.33 3.79 64  11.39 3.74 36 
ICD Cons 0.02 0.98 50  -0.04 0.95 29 
ICD Pros* -0.17 0.10 50  0.30 0.78 29 
* = p < .001. 
** = p < .05. 
 
Examination of Site and Race Differences 
As noted in Table 4, the Stanford sample was predominantly comprised of 
Caucasian participants, and a relatively larger proportion of the ECU sample was 
African American participants. As such, there was interest in further examining site and 
race differences. Post-hoc analyses consisting of several t-tests were conducted to 
examine within site and within race comparisons. Because there were only 2 African 
American participants within the Stanford group, differences between Caucasian and 
African American participants on socioeconomic and psychosocial variables at Stanford 
were not made. Also for this reason, comparisons were not made between Stanford’s 
African American participants and East Carolina’s African American participants. 
Because there were significant differences between Stanford and East Carolina 
participants in terms of family income, years of education, and insurance, and these 
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same differences appeared when Caucasian and African American participants were 
compared within the entire sample, comparisons between Caucasian and African 
American participants were made within the ECU group only, as well as within 
Caucasian participants between each site. Also, because there were significant 
differences between Stanford and East Carolina participants in terms of anxiety, 
depression, religious health fatalism, and ICD Cons, and differences in anxiety, religious 
health fatalism, and ICD Cons also appeared when Caucasian and African American 
participants were compared within the entire sample, differences by race were 
examined within the East Carolina group only, as well as between Caucasian 
participants at each site. 
Differences by Race within the East Carolina Sample. Socioeconomic 
comparisons between Caucasian and African American participants within the ECU 
sample only revealed no differences in terms of income or education. Caucasian 
participants (M = 0.95, SD = 0.23) were still significantly more likely to have insurance 
coverage than African American participants (M = 0.62, SD = 0.49), t(55.69) = 3.377, p 
= .001, d = .95, 95% CI [.3684, 1.5299]. Psychosocial comparisons by race were also 
examined within the East Carolina group only. African American participants (M = 37.40, 
SD = 10.52), reported significantly higher physical quality of life than Caucasian 
participants (M = 29.77, SD = 8.30), t(57) = 2.904, p = .005, d = .78, 95% CI [.2317, 
1.3253]. African American participants (M = 61.92, SD = 18.85) also reported 
significantly higher religious health fatalism than Caucasian participants (M = 48.36, SD 
= 13.21), t(56) = 3.358, p = .001, d = .91, 95% CI [.3485, 1.4614]. Finally, African 
American participants (M = 0.48, SD = 0.82) reported significantly higher ICD Cons than 
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Caucasian participants (M = -0.26, SD = 0.64), t(50) = 3.303, p = .002, d = .96, 95% CI 
[.3569, 1.5600]. 
Differences by Site between Caucasian Participants. Stanford’s Caucasian 
participants (M = 118.24, SD = 90.67) had significantly higher family income than East 
Carolina’s Caucasian participants (M = 36.44, SD = 25.25), t(20.10) = 3.661, p = .002, d 
= 1.28, 95% CI [.4778, 2.0578]. Stanford’s Caucasian participants (M = 5.64, SD = 3.20) 
had significantly lower anxiety scores than East Carolina’s Caucasian participants (M = 
9.14, SD = 4.59), t(45) = 3.058, p = .004, d = .89, 95% CI [.2879, 1.4913]. Stanford’s 
Caucasian participants (M = 3.24, SD = 2.82) had significantly lower depression scores 
than East Carolina’s Caucasian participants (M = 7.73, SD = 5.16), t(31.58) = 3.632, p = 
.002, d = 1.06, 95% CI [.4251, 1.6842]. Finally, Stanford’s Caucasian participants (M = 
43.69, SD = 10.68) had significantly higher physical quality of life scores than East 
Carolina’s Caucasian participants (M = 29.77, SD = 8.30), t(44) = 4.551, p < .001, d = 
1.34, 95% CI [.6946, 1.9797]. 
Comparisons by Disease Severity  
Independent samples t-tests were then conducted to test differences between 
participants with EFs below 35 versus those with EFs 35 or greater on several outcome 
variables, including ICD Pros and ICD Cons. Means, standard deviations, sample sizes 
appear in Table 17 below. Scores with significant differences were given confidence 
intervals and effects sizes. Participants with EFs below 35 reported lower levels of 
anxiety symptoms than patients with EFs 35 or greater, t(94) = 2.936, p = .004, d = .64, 
95% CI [.2000, 1.0679]. Patients with EFs below 35 reported higher chance locus of 
control than patients with 35 or greater, t(90) = 2.169, p = .033, d = .48, 95% CI [.0395, 
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.9226]. Patients with EFs below 35 reported lower educational background reported 
than patient with EFs 35 or greater, t(83) = 2.915, p = .005, d = .67, 95% CI [.2073, 
1.1345]. There were no significant differences between patients with high versus low 
EFs on ICD Pros or ICD Cons. 
Table 17 
Disease Severity Comparisons 
 General Estimate of Disease Severity 
Measure EF < 35 
“Higher Severity” 
 EF ≥ 35 
“Lower Severity” 
 M SD N  M SD N 
Yearly Income 
(Thousands) 59.56 67.40 42  52.17 60.68 20 
Insurance Coverage 0.82 0.39 60  0.81 0.40 31 
Years of Education** 12.32 3.11 57  14.32 2.65 28 
ICD Intent 5.59 1.73 66  6.00 1.05 28 
HADS Anxiety** 6.80 4.56 66  10.23 6.06 30 
HADS Depression 5.61 4.74 66  7.27 5.66 30 
SF-12 Physical 
Component Score 37.56 10.93 
62  37.18 10.23 30 
SF-12 Mental 
Component Score 50.16 9.68 
62  45.88 12.79 30 
Religious Health 
Fatalism 
Questionnaire 
52.37 18.19 63  50.03 19.21 29 
C-MHLC Internal 25.16 6.21 64  22.53 7.31 30 
C-MHLC Chance** 17.19 6.88 62  13.93 6.50 30 
C-MHLC Doctors 15.48 2.86 65  15.93 2.39 30 
C-MHLC Others 11.45 3.41 65  11.03 4.51 30 
ICD Cons 0.02 1.02 52  0.08 0.88 22 
ICD Pros -0.04 0.96 52  0.05 0.87 22 
* = p < .001. 
** = p < .05. 
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Correlations 
Table 18 below provides the correlations between the various psychosocial and 
socioeconomic variables.  
Table 18 
Correlations 
 
CHAPTER IV:  DISCUSSION 
Summary of Findings 
The current study examined patient decision-making regarding the ICD and 
developed a 2-factor pro and con measurement approach. The ICD-DAS is comprised 
of 22 items, with 2 factors labeled ICD Pros and ICD Cons. The factors (and total scale) 
were found to have high internal consistency and were then used as scales to predict 
whether patient participants would want an ICD if it were recommended by their 
physician. A set of psychosocial measures (i.e., physical and mental quality of life, 
depression, anxiety, locus of control, and religious health fatalism) that assessed 
biological, psychological, social, and spiritual/existential domains were not significantly 
predictive of ICD-Choice, suggesting that the ICD-DAS is a more efficient and accurate 
predictor of patient behavioral intent for the ICD than a combination of these general 
measures. It appears that site differences may have accounted for much of the 
difference in intention to choose the ICD. 
Stanford participants had a significantly higher educational background, yearly 
income, and were significantly more likely to have health insurance than East Carolina 
participants. In addition, East Carolina participants had significantly lower physical 
quality of life scores and significantly higher depression, anxiety, religious health 
fatalism, and ICD Cons than Stanford participants. Finally, Stanford participants had 
significantly higher behavioral intent to choose the ICD than East Carolina participants. 
Caucasian participants had a significantly higher educational background and yearly 
income than African American participants, and were more likely to have health 
insurance than African American participants. African American patients in the sample 
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reported higher levels of depressive symptoms, religious health fatalism, and ICD Cons 
than Caucasian participants. Within the East Carolina sample, Caucasians participants 
were significantly more likely to have insurance coverage than African American 
participants. Also, within the East Carolina group, African American participants 
reported significantly higher physical quality of life, significantly higher religious health 
fatalism, and higher ICD Cons than Caucasian participants. Stanford’s Caucasian 
participants had significantly higher family income, lower anxiety scores, lower 
depression scores, and higher physical quality of life scores than East Carolina’s 
Caucasian participants. Male patients in the sample reported higher levels of internal 
health locus of control and lower levels of ICD Pros than female participants. Those with 
EFs below 35 reported lower levels of anxiety symptoms and higher chance locus of 
control. Those with relatively lower EFs had lower educational backgrounds. There were 
no significant differences between patients with high versus low EFs on ICD Pros or 
ICD Cons. 
Formulation of the ICD-DAS 
 The primary aims of the current study were the initial design and validation of the 
ICD-DAS. This study analyzed selected pros and cons of the ICD that were derived 
from the existing research literature related to health psychology, decision making, and 
ICD patient focused studies, as well as discussions with device experts from both health 
care and the device industry. The items appear to have face validity as they were 
derived directly from the literature regarding risks and benefits and were written in plain, 
easy to read language, and were subjected to expert review. Factor analysis revealed a 
2-factor solution with 11 pros and 11 cons of the ICD. With ICD Cons representing a 
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greater percentage of overall variance, this is consistent with research indicating that 
most patients are more affected by risks than benefits (Alaszewski & Horlick-Jones, 
2003). 
The final factor analysis utilized an Oblimin procedure with Kaiser normalization 
that converged in 5 rotations. The 2 factors were labeled ICD Pros and ICD Cons, 
respectively. ICD Pros and ICD Cons are a simple compilation of the various 
biopsychosocial-spiritual dimensions that were included in the 24-item ICD 
questionnaire that was examined. It was expected that a 4-factor solution would be 
revealed, representing each of the 4 tenets of the Biopsychosocial-Spiritual Model; 
however, the actual solution included each of these 4 components subsumed within the 
ICD Pros and ICD Cons scales. The goal of the following discussion on group 
differences is to explore some of the potential psychosocial, demographic, and 
socioeconomic influences on ICD decision-making.  
The participants enrolled in the present study included a diverse set of patients 
(i.e., regional, disease severity, racial, gender, socioeconomic, and educational 
background), which may allow for generalization of findings across settings. As might be 
expected due to differences in the cost of living, differences in income appeared to be 
accounted for by regional site differences, with higher levels of income reported among 
Stanford’s Caucasian participants than East Carolina’s Caucasian participants. 
Differences in insurance coverage appeared to be primarily related to race, at least in 
the East Carolina sample, with African American participants reporting coverage less 
frequently than Caucasian participants. Psychosocial differences appear to be 
accounted for by a combination of geographical and racial factors. More specifically, 
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Stanford’s Caucasian participants had generally more favorable psychosocial scores 
than East Carolina’s Caucasian participants (i.e., anxiety, depression, and physical 
quality of life). Also, in terms of race within the East Carolina sample, Caucasian 
participants had generally more favorable psychosocial scores than African American 
participants (i.e., religious health fatalism, physical quality of life, and ICD Cons).  
In the East Carolina sample, there were higher percentages of African American 
participants, lower SES participants, and participants with a lower educational status 
than in the Stanford sample. These results might suggest that demographic factors 
potentially influenced behavioral intent to choose the ICD. However, when comparing 
the entire sample’s Caucasian participants with African American participants, and 
when comparing these groups within the East Carolina sample only, there were no 
differences in term of behavioral intent to choose the ICD. Therefore, it appears that site 
differences accounted for most of the difference in intention to choose the ICD. With 
African-American patients reporting higher levels of depressive symptoms, religious 
health fatalism, and ICD Cons than Caucasian participants, it appears that some 
combination of cultural and socioeconomic factors play an important role in the intention 
to choose the ICD. Unfortunately, we were unable to compare African American 
patients between sights do to the low sample of African American patients in the 
Stanford sample. 
Previous research has described ICD disparities and several finding have been 
noted including that African American patients are more likely to refuse 
recommendations (Hernandez et al., 2007), and that geography/region plays an 
important role with lower rates of ICD implant in the southern United States and in 
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regions with larger populations of African Americans (Groeneveld et al., 2007; 
Thomaset al., 2007). Some have suggested that differences in implantation rates are 
due to bias in treatment recommendations (van Ryn, 2002), while others have asserted 
that differences are more related to variations in each patient’s willingness to accept 
recommendations (Gordon et al., 2004; Whittle, Conigliaro, Good, & Joswiak, 1997).  
The site and race differences in terms of ICD behavioral intent in the current 
study may suggest that individuals in the Stanford region are more comfortable with the 
technology of the ICD, which could be attributed to higher education levels, having more 
income, and having insurance coverage to pay for treatment. However, these 
differences could also be due to the higher rates of religious health fatalism and lower 
understanding of the ICD technology in the East Carolina region. The results may also 
suggest that African American patients are more reluctant to receive the ICD because 
the technology is contrary to their spiritual/existential beliefs, as is consistent with their 
higher rates of religious health fatalism compared Caucasian participants. The findings 
may also suggest that having lower socioeconomic status, such as was found in the 
East Carolina sample, leads to a lower likelihood of accepting the ICD, because the 
technology may be neither affordable nor well understood. With higher ratings of ICD 
Cons, this might indicate that African American patients have a relatively greater desire 
to avoid the negative implications of the device, or these factors create less cognitive 
dissonance in terms of relatively higher rates of fatalistic religious beliefs. With the 
current sample of African American patients reporting relatively higher levels of 
depression, this may also suggest poorer emotional adjustment to cardiac disease, or a 
more negatively focused cognitive schema, as would be consistent with depression. 
78
 
Having higher depressive symptoms may also contribute to a negative perception of the 
ICD. Interestingly, Stanford’s Caucasian participants had significantly lower depression 
scores than East Carolina’s Caucasian participants. This lends support to the possibility 
that the differences in depression may be less attributed to race than to region. Overall, 
it appears that both region and race play important roles in terms of patient perceptions 
of the ICD.  
Male patients in the sample reported higher levels of internal health locus of 
control and lower levels of ICD Pros than female participants. Males may be less likely 
to give weight to the benefits of treatment recommendations (relatively lower ICD Pros) 
and be less likely to follow the advice of their physician (relatively higher internal locus 
of control). Alternatively, females may be more likely to follow the advice of their 
physician (relatively lower internal locus of control) and give more weight to the benefits 
of a treatment than men (relatively lower ICD pros). This is an interesting finding from 
which conclusions are not easily drawn, and therefore, further exploration in a 
subsequent analysis may be worthwhile.  
Those with EFs below 35 reported lower levels of anxiety symptoms and higher 
chance locus of control. Again, this is an interesting finding that might suggest that 
patients with greater disease severity have accepted their disease more (and therefore 
have lower anxiety), and lend control to external factors (higher chance locus of control) 
since they may perceive their behavior as less predictive of improvement in their health. 
Those with relatively lower EFs had lower educational backgrounds, which could 
potentially suggest that lower socioeconomic status is related to poorer health in our 
sample. It is notable that there were no significant differences between patients with 
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high versus low EFs on ICD Pros or ICD Cons, which may indicate that patient weight 
pros and cons in similar ways no matter how severe or threatening their illness. Despite 
East Carolina participants having relatively higher EFs than Stanford participants, they 
reported lower physical quality of life than Stanford patients. This discrepancy may be 
attributed to socioeconomic or psychosocial factors.   
The group differences just described on biological, psychological, social, and 
spiritual dimensions support the current study’s conceptualization applying the 
Biopsychosocial-Spiritual Model of health. This model, combined with theories of health 
related decision-making (Transtheoretical Model and Theory of Planned Behavior), was 
utilized in order to create a testable measure informed by the literature. Informed by 
these theories, the current study sought to design a measure that could be empirically 
validated by assessment of important ICD-related factors.  
The Biopsychosocial-Spiritual Model was utilized to account for a holistic set of 
factors that could be assessed to best predict the conditional behavioral intention to 
choose the ICD. While there was no specific method to confirm this model in the final 
ICD-DAS measure, the final set of items on the measure included items from all 4 
tenets of this model. The health psychology literature clearly suggests that biological, 
psychological, and social factors interact to influence behavior; however, there is 
relatively limited evidence to support adding a spiritual/existential dimension to the well-
accepted 3-factor model. Our current study suggests that spiritual factors may be 
important to ICD patients, but this does not assume that a fourth dimension should be 
added to the Biopsychosocial-Spiritual Model because spirituality can be conceptualized 
as a psychological or social variable. On one hand, there may negative implications 
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related to fatalism, and on the other hand, patients have the right to choose treatment 
options based on their beliefs about life and death. Incorporation of 
spirituality/existentialism items into the ICD decisional model appears important, in part 
because a life changing decision is being made. While spirituality can be conceptualized 
as a social factor (e.g., religious community) or even a psychological factor (e.g., belief 
or cognition), if  ICD patients perceive their spirituality as a determining decision factor, 
simply addressing cognitive and social facets may come across to patients as 
insufficient.  
The Transtheoretical Model and the Theory of Planned Behavior appear to 
provide useful frameworks for the items on the ICD-DAS. The Transtheoretical Model’s 
concept of weighing the pros and cons of a decision was confirmed in this study, with 
ICD pros and ICD cons being retained as distinct subscales on the ICD-DAS. However, 
there was no method of confirming what stage of change an individual was in during 
their rating of behavioral intent to choose ICD. Future analyses may compare 
individuals who were actually making the ICD choice with those who were not. The 
Theory of Planned Behavior, with its focus on relevant beliefs and normative influences 
was applicable, as ICD Pros and ICD Cons successfully predicted behavior intent to 
choose the ICD when recommended by their physician. A next phase of the study might 
attempt to use behavioral intent to predict actual ICD choice. The concept of assessing 
beliefs is important as heuristic tendencies may at times appropriately guide decisions, 
while factors such as physician reliance, availability heuristics, depression, or religious 
health fatalism may influence patients to choose the ICD without full understanding of 
the facts. The use of decision analysis attempts to account for these decisional 
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influences by clearly representing, and formally assessing the important aspects of a 
decision situation with the goal of removing ambiguity from choice and focusing 
attention on the uncertainties that may change or influence one’s decision. Although 
previous research has documented a variety of positive and negative perceptions about 
the ICD, no studies are available which address the ICD decision by a decision analysis 
approach.  
The ultimate improvement of pre-implant education and allowing for interventions 
with potential ICD recipients was the heart of this study. There are a variety of post-
implant educational and cognitive-behavioral interventions that could be applied to 
potential ICD recipients. The current study demonstrated that behavioral intent to 
choose the ICD might vary depending on demographic, regional, and socioeconomic 
variables. Future efforts will focus on assessing and improving patient readiness with 
similar interventions that are tailored to the factors they rate as important on the ICD-
DAS. It is predicted ICD-indicated patients, who are referred through this process that 
includes assessment and subsequent implementation of tailored education and 
intervention, will make informed and confident decisions regarding treatment with an 
ICD.  
If patients choose to refuse the ICD based on an inclusive array of information 
about the pros and cons of ICD-treatment, then hopefully their quality of life and 
psychological well being is spared as they will not experience the negative implications 
associated with ICD cons such as shock or cognitive dissonance with their spiritual 
beliefs.  If patients choose the ICD more often because of an inclusive array of 
information about the pros and cons of ICD-treatment, then ICD treatment for sudden 
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cardiac arrest will be utilized to a greater degree, which will lead to prevention of 
unnecessary or untimely deaths.  
Limitations 
In part 1 of the study, the initial ICD-DAS was constructed after a literature review 
and use of a Biopsychosocial-Spiritual Model for conceptualization purposes. In 
assessing Biopsychosocial-Spiritual Model, the current study may not have used the 
best items to tap dimension to accurately test the model. To keep the measure relatively 
brief, there were only 3 pros and 3 cons for each of the 4 dimensions that were 
analyzed with the ICD questionnaire. Ideally, the measure would have kept several of 
the initial 121 items to be analyzed; however, there would have been insufficient 
participants in this study to test such a large number of items.  Further, the subject 
burden in a clinically ill sample was a limitation that needed to be considered. As a 
result, from that outset of this project, a rational item development approach was used 
that was less than ideal in order to reduce the items and limit the time necessary to 
participate in the project.  Another potential limitation is that some of the items were 
worded in too complex a way. Simpler concepts may have reduced potential differences 
in the interpretation of items.  
Once the items were identified, experts reviewed the items; however, there were 
no assessments of inter-rater reliability. Methodology was not formal between the 
principal investigator and expert interviewees while they reviewed the proposed set of 
items. Ideally, there would have been a formal qualitative assessment of patients prior 
to the administration to experts. Then, experts would rate each item blindly to prevent 
bias toward confirming the preconceived rational groupings of items. Another planning 
83
 
issue included an initial overestimation of the number of patients who were actually 
going to be making the final ICD decision at the time of our assessments. This led to 
broadening the inclusion criteria to include patients who would not be making impending 
decisions. In part 2 of the study, patients were administered the initial ICD-DAS and 
other measures. Investigators reported that a number of patients appeared confused 
when scoring portions of the ICD-DAS (i.e. Agree/disagree items and qualitative 
portions). Ideally, the questionnaire would have been designed to ask all 24 
agree/disagree items first and then subsequently ask each of the 24 importance items. 
The inclusion of the Religious Health Fatalism Questionnaire inherently put a negative 
spin on the items that assessed spiritual considerations. Ideally, a measure that could 
distinguish positive from negative religious coping would have been potentially less 
stigmatizing and more encompassing of a range of consequences of spirituality and 
religiosity. 
While there was diversity between the 2 participating sites, samples from Eastern 
North Carolina (East Carolina University) and Palo Alto, California (Stanford University) 
are unique groups and a national or international sample would have allowed for greater 
generalizability. Nonetheless, the current sample did have a wide range of income, 
educational status, race, gender, and disease severity. Unfortunately, there were only 2 
African American participants in the Stanford sample, which did not allow for within 
group comparison by race, or between group differences between African American 
participants. There were also insufficient participants from other ethnic groups to 
determine other culturally related distinctions. 
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In terms of disease severity, there were no differences on any measure between 
patients with low versus high EFs. High versus low cutoffs were selected to reflect ICD 
indicated vs. non-ICD indicated.  Additional research with a focus on only patients who 
are at the actual decision point for choosing whether or not to receive the device may 
still be warranted to confirm whether the results would be the same solely for patients in 
the actual decision context of the ICD. Additional attention to the relationship between 
disease and symptom severity and ICD intent/ICD choice is warranted.  Moreover, 
future investigators may want to control for primary versus secondary prevention 
reasons for implantation of a device. Regarding ejection fraction as a measure of 
severity of illness, our sample assessed 5 patients with relatively high EFs, but who still 
met criteria for the ICD (e.g., structural heart defect). In this light, EF is not necessarily 
the best measure of disease severity especially when considering the medical diversity 
in this sample. Unfortunately, other measures of cardiac severity were not consistently 
collected or available and could not be used in the current set of analyses. The inclusion 
of additional biomedical clinical data for more accurate markers of disease severity 
would add to the validity of the findings being reported and should be considered in 
future research. Nonetheless, previous studies have demonstrated how psychosocial 
adjustment is poorly predicted by disease severity in both congestive heart failure and 
ICD samples (Carels, 2004; Sears et al., 2004). 
Finally, there is uncertainty as to whether or not this measure will ultimately 
improve a patient’s readiness to make a decision regarding the ICD or eventual device 
acceptance if a patient does choose the device. The ultimate utility of the ICD-DAS was 
not fully tested here.  As in most decisions, satisfaction is often independent of weighing 
85
 
pros and cons and is often based on if the decision turns out well or not. Nonetheless, if 
efforts to utilize this measure only manage to improve patient knowledge, provide peace 
of mind during their decision, or instill confidence in their decision, this would be 
sufficient to justify the development and use of the ICD-DAS. However, there is hope 
that that this measure can be utilized to reduce distress and improve patient satisfaction 
in patients after treatment decisions are made. With patient acceptance an uncertainty, 
it is believed that education of patients will be improved regardless, as pro/con 
discussions are not universally the standard of care when ICDs are recommended. 
Future Implications and Aims 
The initial use of the ICD-DAS will be to help patients make more informed 
device decisions. The evidence provided by the current research indicates that there is 
potential benefit from the ICD-DAS prior to device choice as a tool to guide patient 
specific education. Patients will rate pro and con items by importance in their ICD-
decision, and this will allow for more candid discussions with their providers. In addition, 
the ICD-DAS could also be utilized for targeted treatment and simple educational 
modules to be applied to individual items that patients can rate as relatively more 
important on the ICD-DAS. An example of these simple modules has been developed 
for decision-making regarding treatment for breast cancer and was found to be 
acceptable and not cause distress in patients (Sepucha, Ozanne, Partridge, & Moy, 
2009). In this set of modules, patients are assessed regarding their knowledge about 
treatment options, their most salient goals and concerns, and their readiness to make a 
treatment decision. A subsequent phase of this project will be the development of 
treatment and education modules for prospective ICD recipients. 
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Another step will be to analyze patients who, for example, rate cons as high and 
pros as low, yet still have relatively high behavioral intent to choose the ICD. This may 
offer insight into the patient’s decision making patterns and allow for a better 
understanding of motivational factors in making the ICD choice. Alternatively, it would 
be interesting to further explore patient presentations with, for example, low cons, high 
pros, and low behavioral intent to choose the ICD. By gaining a greater appreciation of 
how patients ultimately make their decision, we may be able have more informed 
conversations with patients. If patients eventually decide to proceed toward device 
implantation, this tool could be used to improve patient acceptance of the ICD by 
reducing instances of patients having unaddressed concerns pre-implant.  
Finally, future research should compare device recipients who have normal 
education pre-implant versus those who receive tailored patient education based on this 
measure. Both groups would take the ICD-DAS pre-implant, but only a randomized 
subset of participants would receive tailored treatment and/or education. Future 
investigations should also involve test–retest comparisons. 
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Conclusion 
Optimizing patient decisions regarding device technologies remains a critical 
consideration for informed consent. Decision-making for new and improved 
technologies will increasingly become more difficult given the chasm between patient 
understanding and the advance of technology. The current research suggests that 
assessing pros and cons of the ICD may predict their choice for the ICD. The ICD-DAS 
is an empirically based starting point for attempting to improve the ICD decision making 
process and warrants more research. Further exploration of the design and practical 
implementation of this scale will be addressed in future work. If intervention can address 
patient concerns and provide meaningful knowledge, the quality of patient decisions is 
likely to improve. 
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